{ "instance": { "ocdx-20220102.htm": { "axisCustom": 0, "axisStandard": 47, "contextCount": 599, "dts": { "calculationLink": { "local": [ "ocdx-20220102_cal.xml" ] }, "definitionLink": { "local": [ "ocdx-20220102_def.xml" ] }, "inline": { "local": [ "ocdx-20220102.htm" ] }, "labelLink": { "local": [ "ocdx-20220102_lab.xml" ] }, "presentationLink": { "local": [ "ocdx-20220102_pre.xml" ] }, "schema": { "local": [ "ocdx-20220102.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 1112, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 15, "http://orthoclinical.com/20220102": 4, "http://xbrl.sec.gov/dei/2021q4": 4, "total": 23 }, "keyCustom": 171, "keyStandard": 610, "memberCustom": 74, "memberStandard": 81, "nsprefix": "ocdx", "nsuri": "http://orthoclinical.com/20220102", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Basis of presentation of the consolidated financial statements", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBasisOfPresentationOfConsolidatedFinancialStatements", "shortName": "Basis of presentation of the consolidated financial statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101060 - Disclosure - Long-term Employee Benefits - Schedule Of Expected Benefit Payments (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails", "shortName": "Long-term Employee Benefits - Schedule Of Expected Benefit Payments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101070 - Disclosure - Long-term Employee Benefits - Defined Benefit Plan, Plan Assets, Category (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "shortName": "Long-term Employee Benefits - Defined Benefit Plan, Plan Assets, Category (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0279cfd3-f3a5-42b2-bc85-ec2c75c0b9c9", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101080 - Disclosure - Long-term Employee Benefits - Schedule of Allocation of Plan Assets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails", "shortName": "Long-term Employee Benefits - Schedule of Allocation of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_08192e62-5611-4f14-b530-00f02f264bc2", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanSettlementsPlanAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "div", "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingCostsAndExpenses", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101090 - Disclosure - Other Financial Information - Summary of Components for Certain Captions (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails", "shortName": "Other Financial Information - Summary of Components for Certain Captions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "div", "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101100 - Disclosure - Other Financial Information - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationAdditionalInformationDetails", "shortName": "Other Financial Information - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R105": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101110 - Disclosure - Income Taxes - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "shortName": "Income Taxes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R106": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101120 - Disclosure - Income Taxes - Summary of Income (Loss) from Continuing Operations before Income Taxes (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeLossFromContinuingOperationsBeforeIncomeTaxesDetails", "shortName": "Income Taxes - Summary of Income (Loss) from Continuing Operations before Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R107": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101130 - Disclosure - Income Taxes - Schedule of Income Tax Provisions (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails", "shortName": "Income Taxes - Schedule of Income Tax Provisions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R108": { "firstAnchor": { "ancestors": [ "span", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101140 - Disclosure - Income Taxes - Schedule of Reconciliation of Income Tax Provision To The U.S. Statutory Rate (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails", "shortName": "Income Taxes - Schedule of Reconciliation of Income Tax Provision To The U.S. Statutory Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "3", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R109": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101150 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Summary of Significant Accounting Policies", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R110": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101160 - Disclosure - Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefit Activity (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitActivityDetails", "shortName": "Income Taxes - Summary of Reconciliation of Unrecognized Tax Benefit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R111": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101170 - Disclosure - Income Taxes - Summary of Changes To The Valuation Allowance (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesToTheValuationAllowanceDetails", "shortName": "Income Taxes - Summary of Changes To The Valuation Allowance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:SummaryOfValuationAllowanceTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "ocdx:DeferredTaxAssetsValuationAllowanceAdditionsDeductions", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R112": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101180 - Disclosure - Stock-based compensation - Schedule of Stock-Based Compensation Under Statements Of Operations (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails", "shortName": "Stock-based compensation - Schedule of Stock-Based Compensation Under Statements Of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_53ace181-f14f-491e-bf2a-9afea5036b90", "decimals": "-5", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R113": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101190 - Disclosure - Stock Based Compensation - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "shortName": "Stock Based Compensation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "ocdx:AdditionalStockBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R114": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101200 - Disclosure - Stock-based compensation - Summary of Option, Activity (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails", "shortName": "Stock-based compensation - Summary of Option, Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R115": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101210 - Disclosure - Stock-based compensation - Assumptions Used to Estimated Grant Fair Value (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "shortName": "Stock-based compensation - Assumptions Used to Estimated Grant Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R116": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101220 - Disclosure - Stock-based compensation - Schedule of Performance Based Awards Grant Fair Value (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "shortName": "Stock-based compensation - Schedule of Performance Based Awards Grant Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_60f6d38f-71fa-419b-aa2a-9ce2521fbd7e", "decimals": "2", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R117": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_c27d812a-bbe7-433c-a697-8316bdb4434f", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101230 - Disclosure - Stock-based compensation - Summary of Restricted Stock Activity (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails", "shortName": "Stock-based compensation - Summary of Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_c27d812a-bbe7-433c-a697-8316bdb4434f", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R118": { "firstAnchor": { "ancestors": [ "span", "p", "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:NoncashTransferOfInventoryToPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101240 - Disclosure - Noncash investing and financing activities - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivitiesAdditionalInformationDetails", "shortName": "Noncash investing and financing activities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:NoncashTransferOfInventoryToPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R119": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "U_Segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101250 - Disclosure - Segment and Geographic Information - Additional Information (Detail)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdditionalInformationDetail", "shortName": "Segment and Geographic Information - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "U_Segment", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Revenue", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R120": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101260 - Disclosure - Segment and Geographic Information - Net Revenue by Segment (Detail)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "shortName": "Segment and Geographic Information - Net Revenue by Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_09935a9a-c499-4f4d-a84e-20b54f2e814b", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R121": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101270 - Disclosure - Segment and Geographic Information - Adjusted EBITDA by Segment (Detail)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "shortName": "Segment and Geographic Information - Adjusted EBITDA by Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "ocdx:ArbitrationAward", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R122": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101280 - Disclosure - Segments and geographic information - Management EBITDA by segment (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "shortName": "Segments and geographic information - Management EBITDA by segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:ManagementEarningsBeforeInterestTaxDepreciationAndAmortizationTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_19404699-b35e-4cbf-8139-30f3fde05ae6", "decimals": "-5", "lang": null, "name": "ocdx:ManagementAdjustmentsAndRealizedForeignExchangeLosses", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R123": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101290 - Disclosure - Segment and Geographic Information - Net Revenue by Company's Country of Domicile (Detail)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "shortName": "Segment and Geographic Information - Net Revenue by Company's Country of Domicile (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_3e640428-f46b-4326-8e4d-c889f82ecfa4", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R124": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101300 - Disclosure - Segment and Geographic Information - PPE and ROU Assets by Company's Country of Domicile (Detail)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail", "shortName": "Segment and Geographic Information - PPE and ROU Assets by Company's Country of Domicile (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R125": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101310 - Disclosure - Related party transactions - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "shortName": "Related party transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_9060dbbf-1b03-4c3d-9684-3a65d561ff9c", "decimals": "-5", "lang": null, "name": "us-gaap:DueToRelatedPartiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R126": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_7b005227-2025-45d1-9db2-a14f653fafb1", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101320 - Disclosure - Fair Value Accounting - Schedule of Fair Value of Long-term Borrowings (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails", "shortName": "Fair Value Accounting - Schedule of Fair Value of Long-term Borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_7b005227-2025-45d1-9db2-a14f653fafb1", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R127": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101330 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R128": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_3dbf5f05-8f3a-4520-9a72-b774639115e1", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:InterestRateDerivativeAgreementsEffectiveDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101340 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_3dbf5f05-8f3a-4520-9a72-b774639115e1", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:InterestRateDerivativeAgreementsEffectiveDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R129": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_1a42f07b-490a-4f28-81f0-0c8d150bab7b", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101350 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Parenthetical) (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_680d6e63-23df-40ac-864b-40383ad30dd2", "decimals": "INF", "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Inventories", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R130": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_1a42f07b-490a-4f28-81f0-0c8d150bab7b", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101360 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments Outstanding (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:ScheduleOfForeignCurrencyForwardContractsOutstandingTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_e31e158e-2067-43bd-b558-d5d1efde04c0", "decimals": "INF", "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R131": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_520fe330-af6a-4d91-9b47-fdaad3ea82ba", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101370 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gains and Losses from Designated Derivative and Non-derivative Instruments within AOCI (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Gains and Losses from Designated Derivative and Non-derivative Instruments within AOCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_520fe330-af6a-4d91-9b47-fdaad3ea82ba", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R132": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101380 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Designated Derivative Instruments within Interest Expense, Net and Cost of Revenue in Statements of Operations (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Designated Derivative Instruments within Interest Expense, Net and Cost of Revenue in Statements of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_3dbf5f05-8f3a-4520-9a72-b774639115e1", "decimals": "-5", "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R133": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0d7bd9db-3497-4148-979a-5af1024b5159", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101390 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Fair value gains and losses of derivative contracts (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Fair value gains and losses of derivative contracts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0d7bd9db-3497-4148-979a-5af1024b5159", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R134": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0fbab9d5-0fa8-405b-bb0d-c8d879a43a5f", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101400 - Disclosure - Derivative Instruments and Hedging Activities - Location and Fair Values of Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "shortName": "Derivative Instruments and Hedging Activities - Location and Fair Values of Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0fbab9d5-0fa8-405b-bb0d-c8d879a43a5f", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R135": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_2c534f2a-d3e4-4c8b-911f-ec4d67f6c3b4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101410 - Disclosure - Derivative Instruments and Hedging Activities - Location and Fair Values of Non-Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "shortName": "Derivative Instruments and Hedging Activities - Location and Fair Values of Non-Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_2c534f2a-d3e4-4c8b-911f-ec4d67f6c3b4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R136": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101420 - Disclosure - Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "shortName": "Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_9cdecbfe-687b-4e22-8793-02ae265dc43f", "decimals": "-5", "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R137": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101430 - Disclosure - Financial Information of Registrant (Parent Company Only) - Schedule of Statement of Operation and Comprehensive Loss (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "shortName": "Financial Information of Registrant (Parent Company Only) - Schedule of Statement of Operation and Comprehensive Loss (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fdaf8487-22d8-4aaf-b1fb-c8f4a2b9d679", "decimals": "-5", "lang": null, "name": "us-gaap:OtherSellingAndMarketingExpense", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R138": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101440 - Disclosure - Financial Information of Registrant (Parent Company Only) - Schedule of Statements of Balance Sheets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "shortName": "Financial Information of Registrant (Parent Company Only) - Schedule of Statements of Balance Sheets (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_762ba8c1-1e98-4f6e-b26d-7d81623ecdf9", "decimals": "-5", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R139": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101450 - Disclosure - Financial Information of Registrant (Parent Company Only) - Schedule of Statements of Balance Sheets (Details) (Parenthetical)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "shortName": "Financial Information of Registrant (Parent Company Only) - Schedule of Statements of Balance Sheets (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_762ba8c1-1e98-4f6e-b26d-7d81623ecdf9", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Property, plant and equipment, net", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentNet", "shortName": "Property, plant and equipment, net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R140": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101460 - Disclosure - Financial Information of Registrant (Parent Company Only) - Schedule of Statements of Cash Flows (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "shortName": "Financial Information of Registrant (Parent Company Only) - Schedule of Statements of Cash Flows (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "srt:ScheduleOfCondensedCashFlowStatementTableTextBlock", "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fdaf8487-22d8-4aaf-b1fb-c8f4a2b9d679", "decimals": "-5", "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R141": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_9d9fecee-2956-4683-b285-c8a0c3b192fa", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101470 - Disclosure - Financial Information of Registrant (Parent Company Only) (Additional Information) (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails", "shortName": "Financial Information of Registrant (Parent Company Only) (Additional Information) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_9d9fecee-2956-4683-b285-c8a0c3b192fa", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Goodwill and Other Intangible Assets", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssets", "shortName": "Goodwill and Other Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Other Asset", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAsset", "shortName": "Other Asset", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Borrowings", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings", "shortName": "Borrowings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Leases", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Accrued Liabilities", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilities", "shortName": "Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Consolidated Statements of Operations", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "us-gaap:OtherOperatingIncomeExpenseNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Restructuring Costs", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCosts", "shortName": "Restructuring Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Collaborations and other relationships", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationships", "shortName": "Collaborations and other relationships", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Long-Term Employee Benefits", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefits4", "shortName": "Long-Term Employee Benefits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Other Financial Information", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureOtherFinancialInformation1", "shortName": "Other Financial Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Income Taxes", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxes1", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Stock-Based Compensation", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensation1", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Noncash investing and financing activities", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureNoncashInvestingAndFinancingActivities", "shortName": "Noncash investing and financing activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Segments and Geographic Information", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformation", "shortName": "Segments and Geographic Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Related party transactions", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRelatedPartyTransactions", "shortName": "Related party transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Commitments and contingencies", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "shortName": "Commitments and contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Consolidated Statements of Comprehensive Loss", "role": "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss", "shortName": "Consolidated Statements of Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Fair Value Accounting", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFairValueAccounting1", "shortName": "Fair Value Accounting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Derivative Instruments and Hedging Activities", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivities1", "shortName": "Derivative Instruments and Hedging Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Accumulated Other Comprehensive Loss", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLoss", "shortName": "Accumulated Other Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Financial Information of Registrant (Parent Company Only)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnly", "shortName": "Financial Information of Registrant (Parent Company Only)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UseOfEstimates", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:EarningsPerSharePolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Revenue (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Inventories (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:PropertyPlantEquipmentAndAccumulatedDepreciationBalancesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Property, plant and equipment, net (Table)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentNetTable", "shortName": "Property, plant and equipment, net (Table)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:PropertyPlantEquipmentAndAccumulatedDepreciationBalancesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Goodwill and Other Intangible Assets (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsTables", "shortName": "Goodwill and Other Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Consolidated Balance Sheets", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Other Asset (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetTables", "shortName": "Other Asset (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Borrowings (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables", "shortName": "Borrowings (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Leases (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:AssetsAndLiabilitiesLesseeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Accrued Liabilities (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesTables", "shortName": "Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Long-Term Employee Benefits (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables", "shortName": "Long-Term Employee Benefits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Other Financial Information (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureOtherFinancialInformationTables", "shortName": "Other Financial Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Income Taxes (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Segments and Geographic Information (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformationTables", "shortName": "Segments and Geographic Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Fair Value Accounting (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingTables", "shortName": "Fair Value Accounting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Derivative instruments and hedging activities (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables", "shortName": "Derivative instruments and hedging activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Accumulated Other Comprehensive Loss (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossTables", "shortName": "Accumulated Other Comprehensive Loss (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:ComprehensiveIncomeNoteTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Financial Information of Registrant (Parent Company Only) (Tables)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyTables", "shortName": "Financial Information of Registrant (Parent Company Only) (Tables)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "2", "first": true, "lang": null, "name": "ocdx:PercentageOfSharesAcquired", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100580 - Disclosure - General and Description of the Business - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "shortName": "General and Description of the Business - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:NatureOfOperations", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "2", "first": true, "lang": null, "name": "ocdx:PercentageOfSharesAcquired", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_94981a24-7172-4790-89c3-a41466030dc1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockSplits", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Basis of presentation of the consolidated financial statements - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureBasisOfPresentationOfTheConsolidatedFinancialStatementsAdditionalInformationDetails", "shortName": "Basis of presentation of the consolidated financial statements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_94981a24-7172-4790-89c3-a41466030dc1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockSplits", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-6", "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:EarningsPerSharePolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - Summary of Significant Accounting Policies - Summary of Potential Ordinary Share Equivalents Outstanding (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails", "shortName": "Summary of Significant Accounting Policies - Summary of Potential Ordinary Share Equivalents Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:EarningsPerSharePolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_735670c9-583d-4569-828d-585f5379a31b", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - Summary of Significant Accounting Policies - Property, Plant and Equipment's Estimated Useful Lives (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails", "shortName": "Summary of Significant Accounting Policies - Property, Plant and Equipment's Estimated Useful Lives (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_735670c9-583d-4569-828d-585f5379a31b", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Revenue - Schedule of Balance of Contract Assets Recorded in Consolidated Balance Sheets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails", "shortName": "Revenue - Schedule of Balance of Contract Assets Recorded in Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Revenue - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "shortName": "Revenue - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_927624df-0173-4a39-956b-7a4822c51d27", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100080 - Statement - Consolidated Statements of Changes in Shareholders' Equity Deficit", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "shortName": "Consolidated Statements of Changes in Shareholders' Equity Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_c2cd56a2-0154-4505-811a-a63134c9b590", "decimals": "-6", "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueNotFromContractWithCustomer", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - Revenue - Summary of Net Revenue by Line of Business (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails", "shortName": "Revenue - Summary of Net Revenue by Line of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0914fe48-172f-4935-9c7f-295c5c909c0e", "decimals": "-5", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:ChangesToRebateReservesTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:RebateReserves", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Revenue - Summary of changes to rebate reserves (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRevenueSummaryOfChangesToRebateReservesDetails", "shortName": "Revenue - Summary of changes to rebate reserves (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:ChangesToRebateReservesTableTextBlock", "div", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_927624df-0173-4a39-956b-7a4822c51d27", "decimals": "-5", "lang": null, "name": "ocdx:RebateReserves", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Inventories - Schedule of Inventories (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails", "shortName": "Inventories - Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:InventoriesTransferedToPropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - Inventories - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesAdditionalInformationDetails", "shortName": "Inventories - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:InventoryDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:InventoriesTransferedToPropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:PropertyPlantEquipmentAndAccumulatedDepreciationBalancesTableTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100690 - Disclosure - Property, plant and equipment, net - Schedule of Property, Plant, Equipment and Accumulated Depreciation Balances. (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "shortName": "Property, plant and equipment, net - Schedule of Property, Plant, Equipment and Accumulated Depreciation Balances. (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:PropertyPlantEquipmentAndAccumulatedDepreciationBalancesTableTextBlock", "div", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "ix:continuation", "span", "p", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100700 - Disclosure - Property, plant and equipment, net - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails", "shortName": "Property, plant and equipment, net - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "span", "p", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Changes In Goodwill (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails", "shortName": "Goodwill and Other Intangible Assets - Schedule of Changes In Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Goodwill and Other Intangible Assets - Summary of Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets - Summary of Gross Carrying Amount and Accumulated Amortization of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100730 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "shortName": "Goodwill and Other Intangible Assets - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R69": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Goodwill and Other Intangible Assets - Summary of Amortization Expenses of Intangible Assets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfAmortizationExpensesOfIntangibleAssetsDetails", "shortName": "Goodwill and Other Intangible Assets - Summary of Amortization Expenses of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:IncomeTaxExpensesOnPensionAndOtherPostemploymentBenefits", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100090 - Statement - Consolidated Statements of Changes in Shareholders' Equity Deficit (Parenthetical)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "shortName": "Consolidated Statements of Changes in Shareholders' Equity Deficit (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:IncomeTaxExpensesOnPensionAndOtherPostemploymentBenefits", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:RightOfUseOfAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100750 - Disclosure - Other Asset - Schedule of component of Other Asset (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails", "shortName": "Other Asset - Schedule of component of Other Asset (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "lang": null, "name": "ocdx:EquityInvestments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unitRef": "U_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100760 - Disclosure - Other Asset - Additional Information (Detail)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail", "shortName": "Other Asset - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fc368a70-fa2b-41fd-825f-f65875851617", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "U_shares", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100770 - Disclosure - Borrowings - Components of Borrowings (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "shortName": "Borrowings - Components of Borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDue", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100780 - Disclosure - Borrowings - Secured Credit Facilities - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "shortName": "Borrowings - Secured Credit Facilities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100790 - Disclosure - Borrowings - 2025 Notes - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "shortName": "Borrowings - 2025 Notes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dc266125-c373-4880-bd1e-79193980a86c", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_72b5c30f-6324-4349-aa08-c107fd454a01", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100800 - Disclosure - Borrowings - Schedule of Redemption Prices of 2025 Notes Expressed as Percentages of Principal Amount (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "shortName": "Borrowings - Schedule of Redemption Prices of 2025 Notes Expressed as Percentages of Principal Amount (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DebtInstrumentRedemptionTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_bbf53352-557a-404c-82c4-d25113abf835", "decimals": "5", "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100810 - Disclosure - Borrowings - 2028 Notes - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "shortName": "Borrowings - 2028 Notes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_94e14c9b-6244-447b-b6e7-3269eb657a3e", "decimals": "-5", "lang": null, "name": "us-gaap:DerivativeAssetNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_1c840fdb-7f0a-4277-a968-bca09aa1bb1a", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100820 - Disclosure - Borrowings - Schedule of Redemption Prices of 2028 Notes Expressed as Percentages of Principal Amount (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "shortName": "Borrowings - Schedule of Redemption Prices of 2028 Notes Expressed as Percentages of Principal Amount (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:DebtInstrumentRedemptionTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_8abda242-4ef5-4d2e-a11e-ddedd7d78bd8", "decimals": "5", "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100830 - Disclosure - Borrowings - 2022 Notes - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "shortName": "Borrowings - 2022 Notes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_3bac7a7e-9132-4060-b8a8-d495fb60372f", "decimals": "-8", "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_7b572812-753d-41d3-879a-84f1de30328c", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:SaleAndLeasebackFinancingAssetsSold", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100840 - Disclosure - Borrowings - Sale and Leaseback Financing - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSaleAndLeasebackFinancingAdditionalInformationDetails", "shortName": "Borrowings - Sale and Leaseback Financing - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_7b572812-753d-41d3-879a-84f1de30328c", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:SaleAndLeasebackFinancingAssetsSold", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100100 - Statement - Consolidated Statements of Cash Flows", "role": "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "lang": null, "name": "us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "4", "first": true, "lang": null, "name": "ocdx:OutstandingBorrowingsInterestRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100850 - Disclosure - Borrowings - Accounts Receivable Financing - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "shortName": "Borrowings - Accounts Receivable Financing - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_dddc05ce-019c-462d-aafd-14400904affe", "decimals": "4", "first": true, "lang": null, "name": "ocdx:OutstandingBorrowingsInterestRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:InterestExpenseDebtNetTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100860 - Disclosure - Borrowings - Schedule of Interest Expense, Net (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "shortName": "Borrowings - Schedule of Interest Expense, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:InterestExpenseDebtNetTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100870 - Disclosure - Borrowings - Schedule of Required Future Repayments of all Borrowings Outstanding (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails", "shortName": "Borrowings - Schedule of Required Future Repayments of all Borrowings Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "div", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100880 - Disclosure - Borrowings - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAdditionalInformationDetails", "shortName": "Borrowings - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100890 - Disclosure - Leases - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails", "shortName": "Leases - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "div", "us-gaap:OtherAssetsDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:RightOfUseOfAssets", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100900 - Disclosure - Leases - Summary of supplemental balance sheet information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfSupplementalBalanceSheetInformationDetails", "shortName": "Leases - Summary of supplemental balance sheet information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:AssetsAndLiabilitiesLesseeTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:SummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100910 - Disclosure - Leases - Summary of Cash Flow Information, Lease Term And Discount Rate of Operating Lease (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseDetails", "shortName": "Leases - Summary of Cash Flow Information, Lease Term And Discount Rate of Operating Lease (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:SummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100920 - Disclosure - Leases - Lessee, Operating Lease, Liability, Maturity (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails", "shortName": "Leases - Lessee, Operating Lease, Liability, Maturity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100930 - Disclosure - Leases - Equipment Leased to Customers (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesEquipmentLeasedToCustomersDetails", "shortName": "Leases - Equipment Leased to Customers (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock", "div", "us-gaap:LesseeOperatingLeasesTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertySubjectToOrAvailableForOperatingLeaseGross", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100940 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails", "shortName": "Accrued Liabilities - Schedule of Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - General and Description of the Business", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusiness", "shortName": "General and Description of the Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_19404699-b35e-4cbf-8139-30f3fde05ae6", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100950 - Disclosure - Restructuring Costs - Additional Infrmation (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails", "shortName": "Restructuring Costs - Additional Infrmation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_19404699-b35e-4cbf-8139-30f3fde05ae6", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100960 - Disclosure - Collaborations and Other Relationships - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "shortName": "Collaborations and Other Relationships - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CollaborativeArrangementDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_6a3b9373-071d-472e-858e-4929339df402", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:RetirementBenefitObligationAmortizationTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100970 - Disclosure - Long-term Employee Benefits - Other Postemployment Benefits - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsAdditionalInformationDetails", "shortName": "Long-term Employee Benefits - Other Postemployment Benefits - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:RetirementBenefitObligationAmortizationTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100980 - Disclosure - Long-term Employee Benefits - Summary of Changes in Projected Benefit Obligation and Plan Assets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails", "shortName": "Long-term Employee Benefits - Summary of Changes in Projected Benefit Obligation and Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_4758ef8a-8aaa-4ca1-bb8f-da8bf6ec777c", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100990 - Disclosure - Long-term Employee Benefits - Other Postemployment Benefits (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "shortName": "Long-term Employee Benefits - Other Postemployment Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_33693062-ddf0-48de-a089-38e32584694c", "decimals": "-5", "lang": null, "name": "ocdx:ServiceCostForOtherPostEmploymentBenefits", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:FairValueOfPlanAssetsForPensionPlans", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101000 - Disclosure - Long-term Employee Benefits - Summary of Defined Benefit Obligation in Excess of Plan Assets (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails", "shortName": "Long-term Employee Benefits - Summary of Defined Benefit Obligation in Excess of Plan Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:FairValueOfPlanAssetsForPensionPlans", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101010 - Disclosure - Long-term Employee Benefits - Summary of Pretax Amounts of Net Periodic Benefit Cost (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsSummaryOfPretaxAmountsOfNetPeriodicBenefitCostDetails", "shortName": "Long-term Employee Benefits - Summary of Pretax Amounts of Net Periodic Benefit Cost (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_0da6a631-36be-4dbc-ba4e-8eefbd5375c7", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax", "reportCount": 1, "unitRef": "U_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101030 - Disclosure - Long-term Employee Benefits - Summary of Net Periodic Benefit Costs (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails", "shortName": "Long-term Employee Benefits - Summary of Net Periodic Benefit Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "ocdx:ScheduleOfComponentsOfNetPeriodicBenefitCost", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_79e02814-5e98-4784-bf1a-7cff701683a5", "decimals": "-5", "lang": null, "name": "us-gaap:DefinedBenefitPlanServiceCost", "reportCount": 1, "unique": true, "unitRef": "U_USD", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101040 - Disclosure - Long-term Employee Benefits - Schedule of Defined Benefit Plans Disclosures (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails", "shortName": "Long-term Employee Benefits - Schedule of Defined Benefit Plans Disclosures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "div", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "us-gaap:DefinedBenefitPlanDescriptionOfDirectionAndPatternOfChangeForAssumedHealthCareCostTrendRate", "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "101050 - Disclosure - Long-term Employee Benefits - Additional Information (Details)", "role": "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails", "shortName": "Long-term Employee Benefits - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "us-gaap:DefinedBenefitPlanDescriptionOfDirectionAndPatternOfChangeForAssumedHealthCareCostTrendRate", "span", "p", "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "div", "body", "html" ], "baseRef": "ocdx-20220102.htm", "contextRef": "C_fed66ddb-066f-4d36-a8df-5261d3c983c9", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1", "reportCount": 1, "unique": true, "unitRef": "U_pure", "xsiNil": "false" } } }, "segmentCount": 161, "tag": { "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM", "terseLabel": "UNITED KINGDOM" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "domainItemType" }, "country_LU": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LUXEMBOURG", "terseLabel": "Luxembourg" } } }, "localname": "LU", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2021", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r836" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r831" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r838" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r830" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r866" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r833", "r834", "r835" ], "lang": { "en-us": { "role": { "label": "Icfr Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r832" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "ocdx_AccountingForBusinessCombinationsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting for Business Combinations.", "label": "Accounting For Business Combinations Policy [Text Block]", "terseLabel": "Accounting for Business Combinations" } } }, "localname": "AccountingForBusinessCombinationsPolicyTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ocdx_AccountsReceivableAndAllowanceForCreditLossesAndConcentrationOfCreditRiskPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts Receivable And Allowance For Credit Losses And Concentration Of Credit Risk [Policy Text Block]", "label": "Accounts Receivable And Allowance For Credit Losses And Concentration Of Credit Risk [Policy Text Block]", "terseLabel": "Accounts Receivable and Allowance for Credit Losses and Concentration of Credit Risk" } } }, "localname": "AccountsReceivableAndAllowanceForCreditLossesAndConcentrationOfCreditRiskPolicyTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ocdx_AccountsReceivableFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts receivable financing.", "label": "Accounts Receivable Financing [Member]", "terseLabel": "Accounts Receivable Financing", "verboseLabel": "Financing Program" } } }, "localname": "AccountsReceivableFinancingMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ocdx_AccruedCommissionAndRebate": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued commission and rebate.", "label": "Accrued Commission And Rebate", "terseLabel": "Accrued commissions and rebates" } } }, "localname": "AccruedCommissionAndRebate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AccruedCompensationAndEmployeeRelatedObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued compensation and employee related obligations.", "label": "Accrued Compensation And Employee Related Obligations", "terseLabel": "Accrued compensation and employee related obligations" } } }, "localname": "AccruedCompensationAndEmployeeRelatedObligations", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AccruedLiabilitiesCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued liabilities current.", "label": "Accrued Liabilities Current [Member]", "terseLabel": "Accrued Liabilities" } } }, "localname": "AccruedLiabilitiesCurrentMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "ocdx_AdditionalAmendmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional amendment.", "label": "Additional Amendment [Member]", "terseLabel": "Additional Amendment" } } }, "localname": "AdditionalAmendmentMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_AdditionalAwardsGrantedPotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAnd510KApplicationsOfCOVID19Tests": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional awards granted, potential payment receivable for development and submission of emergency use authorizations and 510(k) applications of COVID-19 tests.", "label": "Additional Awards Granted Potential Payment Receivable For Development And Submission Of Emergency Use Authorizations And510 K Applications Of C O V I D19 Tests", "terseLabel": "Additional awards granted, potential payment receivable for development and submission of emergency use authorizations and 510(k) applications of COVID-19 tests" } } }, "localname": "AdditionalAwardsGrantedPotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAnd510KApplicationsOfCOVID19Tests", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AdditionalStockBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional stock-based compensation expense.", "label": "Additional Stock Based Compensation Expense", "terseLabel": "Total stock-based compensation" } } }, "localname": "AdditionalStockBasedCompensationExpense", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AdditionalStockSharesIssuedForEachShareOfExistingShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional stock shares issued for each share of existing share.", "label": "Additional Stock Shares Issued For Each Share Of Existing Share", "terseLabel": "Additional share for each existing share" } } }, "localname": "AdditionalStockSharesIssuedForEachShareOfExistingShare", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureBasisOfPresentationOfTheConsolidatedFinancialStatementsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "ocdx_AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjusted earnings before interest, tax, depreciation and amortization.", "label": "Adjusted Earnings Before Interest Tax Depreciation And Amortization", "terseLabel": "Adjusted EBITDA", "totalLabel": "Adjusted EBITDA", "verboseLabel": "Adjusted EBITDA" } } }, "localname": "AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_AdjustedEurocurrencyRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjusted Eurocurrency Rate.", "label": "Adjusted Eurocurrency Rate", "terseLabel": "Adjusted Eurocurrency Rate" } } }, "localname": "AdjustedEurocurrencyRate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_AmortizationOfCapitalLeaseObligationAndOther": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails": { "order": 3.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization Of Capital Lease Obligation And Other", "label": "Amortization Of Capital Lease Obligation And Other", "terseLabel": "Capital lease obligation and other" } } }, "localname": "AmortizationOfCapitalLeaseObligationAndOther", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AmountReceivableOnBusinessCombinationAgreementTerminationByQuidel": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount receivable on Business Combination agreement Termination by Quidel", "label": "Amount receivable on Business Combination agreement Termination by Quidel" } } }, "localname": "AmountReceivableOnBusinessCombinationAgreementTerminationByQuidel", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AmountsRecognizedOnConsolidatedBalanceSheetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amounts recognized on the consolidated balance sheets: [Abstract].", "label": "Amounts Recognized On Consolidated Balance Sheets [Abstract]", "terseLabel": "Amounts recognized on the consolidated balance sheets:" } } }, "localname": "AmountsRecognizedOnConsolidatedBalanceSheetsAbstract", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "ocdx_ArbitrationAward": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Arbitration award", "label": "Arbitration Award", "negatedLabel": "Arbitration award", "terseLabel": "Arbitration award" } } }, "localname": "ArbitrationAward", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets And Liabilities Lessee [Table Text Block]", "label": "Assets And Liabilities Lessee [Table Text Block]", "terseLabel": "Assets and Liabilities, Lessee" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "ocdx_AwardReceivedInConnectionWithArbitrationProceeding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Award received in connection with arbitration proceeding.", "label": "Award Received In Connection With Arbitration Proceeding" } } }, "localname": "AwardReceivedInConnectionWithArbitrationProceeding", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_BaseRateLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Base rate loans.", "label": "Base Rate Loans [Member]", "terseLabel": "Base Rate Loans" } } }, "localname": "BaseRateLoansMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_BasisPercentOfGoodwillImpairment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis Percent of Goodwill Impairment", "label": "Basis Percent of Goodwill Impairment" } } }, "localname": "BasisPercentOfGoodwillImpairment", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_BasisPointStepDownsOfFirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis point step-downs of first lien net leverage ratio.", "label": "Basis Point Step Downs Of First Lien Net Leverage Ratio", "terseLabel": "Basis Point Step Downs Of First Lien Net Leverage Ratio" } } }, "localname": "BasisPointStepDownsOfFirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "ocdx_BasisPointStepDownsOnInterestRateOfFirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis point step-downs on interest rate of first lien net leverage ratio.", "label": "Basis Point Step Downs On Interest Rate Of First Lien Net Leverage Ratio", "terseLabel": "Basis point step-downs on interest rate of first lien net leverage ratio" } } }, "localname": "BasisPointStepDownsOnInterestRateOfFirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Biomedical advanced research and development authority.", "label": "Biomedical Advanced Research And Development Authority [Member]", "terseLabel": "Biomedical Advanced Research and Development Authority" } } }, "localname": "BiomedicalAdvancedResearchAndDevelopmentAuthorityMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_BuildingAndBuildingImprovementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Building and building improvements [Member].", "label": "Building And Building Improvement [Member]", "terseLabel": "Building And Building Improvement" } } }, "localname": "BuildingAndBuildingImprovementMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "ocdx_CapitalizedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capitalized costs.", "label": "Capitalized Costs", "terseLabel": "Capitalized costs" } } }, "localname": "CapitalizedCosts", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_CarlyleInvestmentManagementLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carlyle investment management, l.l.c.", "label": "Carlyle Investment Management L L C [Member]", "terseLabel": "Carlyle Investment Management, L.L.C. [Member]" } } }, "localname": "CarlyleInvestmentManagementLLCMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ChangeInReservesPostAcquisitionForUncertainTaxPosition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in reserves post-acquisition for uncertain tax position.", "label": "Change In Reserves Post-Acquisition For Uncertain Tax Position", "terseLabel": "Change in reserves post-acquisition for uncertain tax position" } } }, "localname": "ChangeInReservesPostAcquisitionForUncertainTaxPosition", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ChangeInReservesPreAcquisitionForUncertainTaxPosition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in reserves pre-acquisition for uncertain tax position.", "label": "Change In Reserves Pre-Acquisition For Uncertain Tax Position", "terseLabel": "Change in reserves pre-acquisition for uncertain tax position" } } }, "localname": "ChangeInReservesPreAcquisitionForUncertainTaxPosition", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ChangesInOperatingAssetsAndLiabilitiesNetOfEffectsOfAcquisitionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Changes in operating assets and liabilities, net of effects of acquisitions [Abstract].", "label": "Changes In Operating Assets And Liabilities Net Of Effects Of Acquisitions [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of effects of acquisitions:" } } }, "localname": "ChangesInOperatingAssetsAndLiabilitiesNetOfEffectsOfAcquisitionsAbstract", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ocdx_ChangesInPlanAssetsAndBenefitObligationsRecognizedInOtherComprehensiveLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Changes in plan assets and benefit obligations recognized in other comprehensive loss: [Abstract].", "label": "Changes In Plan Assets And Benefit Obligations Recognized In Other Comprehensive Loss [Abstract]", "terseLabel": "Changes in plan assets and benefit obligations recognized in other comprehensive loss:" } } }, "localname": "ChangesInPlanAssetsAndBenefitObligationsRecognizedInOtherComprehensiveLossAbstract", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "ocdx_ChangesToRebateReservesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Changes to rebate reserves.", "label": "Changes To Rebate Reserves Table [Text Block]", "terseLabel": "Summary of changes to rebate reserves" } } }, "localname": "ChangesToRebateReservesTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "ocdx_ClinicalLaboratoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clinical laboratories.", "label": "Clinical Laboratories [Member]", "terseLabel": "Clinical Laboratories" } } }, "localname": "ClinicalLaboratoriesMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "ocdx_CollaborationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborations [Member]", "label": "Collaborations [Member]", "terseLabel": "Collaborations" } } }, "localname": "CollaborationsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ComputerSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Software [Member].", "label": "Computer Software [Member]", "terseLabel": "Computer Software" } } }, "localname": "ComputerSoftwareMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "ocdx_ConsultingFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting fee.", "label": "Consulting Fee", "terseLabel": "Consulting fees" } } }, "localname": "ConsultingFee", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ConsultingServiceAgreementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting service agreement period.", "label": "Consulting Service Agreement Period", "terseLabel": "Agreement, initial term" } } }, "localname": "ConsultingServiceAgreementPeriod", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ocdx_ConsultingServicesCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting services company.", "label": "Consulting Services Company [Member]", "terseLabel": "Consulting Services Company" } } }, "localname": "ConsultingServicesCompanyMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ContractManufacturingAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract manufacturing agreements.", "label": "Contract Manufacturing Agreements [Member]", "terseLabel": "Contract Manufacturing Agreements" } } }, "localname": "ContractManufacturingAgreementsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ContractualArrangementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangements.", "label": "Contractual Arrangements [Member]", "terseLabel": "Contractual Arrangements" } } }, "localname": "ContractualArrangementsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_Corporate": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Corporate", "label": "Corporate" } } }, "localname": "Corporate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_CostOfRevenueExcludingAmortizationOfIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost of revenue excluding amortization of intangible assets.", "label": "Cost Of Revenue Excluding Amortization Of Intangible Assets [Member]", "terseLabel": "Cost of Revenue Excluding Amortization of Intangible Assets" } } }, "localname": "CostOfRevenueExcludingAmortizationOfIntangibleAssetsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat" ], "xbrltype": "domainItemType" }, "ocdx_CostOfRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost of revenue.", "label": "Cost of Revenue [Member]", "terseLabel": "Cost of Revenue" } } }, "localname": "CostOfRevenueMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "ocdx_CostOfRevenuePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost of Revenue, Percentage.", "label": "Cost Of Revenue Percentage", "terseLabel": "Cost of Revenue, Percentage" } } }, "localname": "CostOfRevenuePercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_CostsRelatedToInitialPublicAndSecondaryOfferings": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs related to initial public and secondary offerings.", "label": "Costs Related To Initial Public And Secondary Offerings", "terseLabel": "Costs related to Ortho's initial public and secondary offerings" } } }, "localname": "CostsRelatedToInitialPublicAndSecondaryOfferings", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_CostsRelatedToOrthosInitialPublicAndSecondaryOfferings": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs related to Ortho's initial public and secondary offerings", "label": "Costs related to Ortho's initial public and secondary offerings" } } }, "localname": "CostsRelatedToOrthosInitialPublicAndSecondaryOfferings", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_CrossCurrencySwapsFairValueHedgeAssetAtFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cross currency swaps fair value hedge asset at fair value.", "label": "Cross Currency Swaps Fair Value Hedge Asset At Fair Value", "terseLabel": "Cross currency interest rate swap contracts" } } }, "localname": "CrossCurrencySwapsFairValueHedgeAssetAtFairValue", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_CrossCurrencySwapsFairValueHedgeLiabilitiesAtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cross Currency Swaps Fair Value Hedge Liabilities At Fair Value.", "label": "Cross Currency Swaps Fair Value Hedge Liabilities At Fair Value", "terseLabel": "Other liabilities" } } }, "localname": "CrossCurrencySwapsFairValueHedgeLiabilitiesAtFairValue", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_CumulativeCashPaymentsForRestructuring": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative cash payments for restructuring.", "label": "Cumulative Cash Payments For Restructuring", "terseLabel": "Cumulative cash payments for restructuring" } } }, "localname": "CumulativeCashPaymentsForRestructuring", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_CumulativeEffectOfChangeInAccountingStandard": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative effect of change in accounting standard.", "label": "Cumulative Effect Of Change In Accounting Standard", "terseLabel": "Cumulative effect of change in accounting standard", "verboseLabel": "Loss from cumulative effect of change in accounting standard" } } }, "localname": "CumulativeEffectOfChangeInAccountingStandard", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_CumulativePreferredStockValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative preferred stock value.", "label": "Cumulative Preferred Stock Value", "terseLabel": "Cumulative Preferred Stock Value" } } }, "localname": "CumulativePreferredStockValue", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_CurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Assets.", "label": "Current Assets [Member]" } } }, "localname": "CurrentAssetsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_CustomerLeasedInstrumentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer leased Instruments [Member].", "label": "Customer Leased Instruments [Member]", "terseLabel": "Customer Leased Instruments" } } }, "localname": "CustomerLeasedInstrumentsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "ocdx_CustomerLeasedInstrumentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer leased instruments.", "label": "Customer Leased Instruments Policy [Text Block]", "terseLabel": "Customer Leased Instruments" } } }, "localname": "CustomerLeasedInstrumentsPolicyTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ocdx_CustomerRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Revenue.", "label": "Customer Revenue [Member]" } } }, "localname": "CustomerRevenueMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_CustomerSupplyAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer supply agreement.", "label": "Customer Supply Agreement [Member]", "terseLabel": "Customer Supply Agreement" } } }, "localname": "CustomerSupplyAgreementMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DebtInstrumentAnnualPrincipalPaymentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument annual principal payment percentage.", "label": "Debt Instrument Annual Principal Payment Percentage", "terseLabel": "Debt instrument annual principal payment percentage" } } }, "localname": "DebtInstrumentAnnualPrincipalPaymentPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_DebtInstrumentMaturityDateYears": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument, maturity date years", "label": "Debt instrument, maturity date years" } } }, "localname": "DebtInstrumentMaturityDateYears", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails" ], "xbrltype": "gYearItemType" }, "ocdx_DebtInstrumentRedemptionPeriodSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument, redemption period seven.", "label": "Debt Instrument Redemption Period Seven [Member]", "terseLabel": "Debt Instrument Redemption Period Seven" } } }, "localname": "DebtInstrumentRedemptionPeriodSevenMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DebtInstrumentRedemptionPeriodSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument, redemption period six.", "label": "Debt Instrument Redemption Period Six [Member]", "terseLabel": "Prior to June 1, 2022" } } }, "localname": "DebtInstrumentRedemptionPeriodSixMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DebtInstrumentWeightedAverageInterestRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument weighted average interest rate percentage.", "label": "Debt Instrument Weighted Average Interest Rate Percentage", "terseLabel": "Debt instrument weighted average interest rate" } } }, "localname": "DebtInstrumentWeightedAverageInterestRatePercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_DebtOfCompanyAcquired": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt of company acquired.", "label": "Debt Of Company Acquired", "terseLabel": "Debt Of Company Acquired" } } }, "localname": "DebtOfCompanyAcquired", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxAssetsCapitalizedTransactionCosts": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Capitalized transaction costs.", "label": "Deferred Tax Assets Capitalized Transaction Costs", "terseLabel": "Capitalized transaction costs" } } }, "localname": "DeferredTaxAssetsCapitalizedTransactionCosts", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxAssetsOperatingLeaseLiability": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets operating lease liability", "label": "Deferred Tax Assets Operating Lease Liability", "terseLabel": "Operating lease liability" } } }, "localname": "DeferredTaxAssetsOperatingLeaseLiability", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxAssetsTaxCreditCarryForwardExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred tax assets tax credit carry forward expiration year.", "label": "Deferred Tax Assets Tax Credit Carry Forward Expiration Year", "terseLabel": "Tax credit carry forwards, expire period" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryForwardExpirationYear", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "gYearItemType" }, "ocdx_DeferredTaxAssetsValuationAllowanceAdditionsDeductions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Valuation Allowance Additions/(Deductions).", "label": "Deferred Tax Assets Valuation Allowance Additions Deductions", "terseLabel": "Additions (deductions) charged to provision for (benefit from) income taxes" } } }, "localname": "DeferredTaxAssetsValuationAllowanceAdditionsDeductions", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesToTheValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxAssetsValuationAllowanceCurrencyTranslationOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Valuation Allowance Currency Translation/Other.", "label": "Deferred Tax Assets Valuation Allowance Currency Translation Other", "terseLabel": "Currency translation/ other" } } }, "localname": "DeferredTaxAssetsValuationAllowanceCurrencyTranslationOther", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesToTheValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxAssetsValuationAllowanceInUnitedStatesAndLuxembourg": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Valuation Allowance In United States and Luxembourg.", "label": "Deferred Tax Assets Valuation Allowance In United States and Luxembourg", "terseLabel": "Deferred tax assets valuation allowance in United States and Luxembourg" } } }, "localname": "DeferredTaxAssetsValuationAllowanceInUnitedStatesAndLuxembourg", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxLiabilitiesDepreciation": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Depreciation.", "label": "Deferred Tax Liabilities Depreciation", "negatedLabel": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "DeferredTaxLiabilitiesDepreciation", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxLiabilitiesRightOfUseAssets": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Right of Use Assets.", "label": "Deferred Tax Liabilities Right Of Use Assets", "negatedLabel": "Right-of-use asset", "terseLabel": "Right-of-use asset" } } }, "localname": "DeferredTaxLiabilitiesRightOfUseAssets", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DeferredTaxLiabilitiesUnrealizedGainLoss": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities, Unrealized (Gain)/Loss.", "label": "Deferred Tax Liabilities Unrealized Gain Loss", "negatedLabel": "Unrealized (gain)/loss", "terseLabel": "Unrealized (gain)/loss" } } }, "localname": "DeferredTaxLiabilitiesUnrealizedGainLoss", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DefinedBenefitPlanBenefitObligationSettlementsAndAmendments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, Benefit Obligation, Settlements and amendments.", "label": "Defined Benefit Plan Benefit Obligation Settlements And Amendments", "terseLabel": "Settlements and amendments" } } }, "localname": "DefinedBenefitPlanBenefitObligationSettlementsAndAmendments", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DefinedBenefitPlanEquitySecuritiesJapanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Equity Securities Japan", "label": "Defined Benefit Plan Equity Securities Japan [Member]", "terseLabel": "Japan equity securities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesJapanMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "ocdx_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextUpcomingYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Upcoming Year.", "label": "Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Upcoming Year", "terseLabel": "Trend rate, down in 2036" } } }, "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextUpcomingYear", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_DefinedBenefitPlanIncomeLossRecognizedInOtherComprehensiveLoss": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 0.0, "parentTag": "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan, (Income) Loss recognized in other comprehensive loss.", "label": "Defined Benefit Plan Income Loss Recognized In Other Comprehensive Loss", "terseLabel": "Total loss (income) recognized in other comprehensive loss", "totalLabel": "Total loss (income) recognized in other comprehensive loss" } } }, "localname": "DefinedBenefitPlanIncomeLossRecognizedInOtherComprehensiveLoss", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DefinedBenefitPlanInsuranceContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Insurance Contracts", "label": "Defined Benefit Plan Insurance Contracts [Member]", "terseLabel": "Insurance contracts" } } }, "localname": "DefinedBenefitPlanInsuranceContractsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "ocdx_DefinedBenefitPlanJapanGovernmentBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Japan Government Bonds", "label": "Defined Benefit Plan Japan Government Bonds [Member]", "terseLabel": "Japan government bonds" } } }, "localname": "DefinedBenefitPlanJapanGovernmentBondsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "ocdx_DefinedBenefitPlanOtherAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Other Assets", "label": "Defined Benefit Plan Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "DefinedBenefitPlanOtherAssetsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DefinedBenefitPlanOtherInternationalGovernmentBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan Other International Government Bonds", "label": "Defined Benefit Plan Other International Government Bonds [Member]", "terseLabel": "Other international government bonds" } } }, "localname": "DefinedBenefitPlanOtherInternationalGovernmentBondsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "ocdx_DefinedBenefitPlanUSGovernmentBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plan US Government Bonds", "label": "Defined Benefit Plan U S Government Bonds [Member]", "terseLabel": "US government bonds" } } }, "localname": "DefinedBenefitPlanUSGovernmentBondsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "ocdx_DefinedBenefitPlansAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plans [Abstract].", "label": "Defined Benefit Plans [Abstract]", "terseLabel": "Defined Benefit Plans" } } }, "localname": "DefinedBenefitPlansAbstract", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsSummaryOfPretaxAmountsOfNetPeriodicBenefitCostDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "ocdx_DefinedBenefitPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Plans", "label": "Defined Benefit Plans [Member]", "terseLabel": "Defined Benefit Plans" } } }, "localname": "DefinedBenefitPlansMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "domainItemType" }, "ocdx_DefinedBenefitReimbursementPlanImplementationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Defined Benefit Reimbursement Plan Implementation Date.", "label": "Defined Benefit Reimbursement Plan Implementation Date", "terseLabel": "Reimbursement plan, implementation date" } } }, "localname": "DefinedBenefitReimbursementPlanImplementationDate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "ocdx_DepositsAndAdvances": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deposits and advances.", "label": "Deposits And Advances", "terseLabel": "Deposits and advances" } } }, "localname": "DepositsAndAdvances", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DerivativeInstruments": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails": { "order": 4.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative Instruments", "label": "Derivative Instruments", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativeInstruments", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DerivativeInstrumentsAndOtherNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative instruments and other Net.", "label": "Derivative Instruments And Other Net", "terseLabel": "Derivative instruments" } } }, "localname": "DerivativeInstrumentsAndOtherNet", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DerivativeInstrumentsDeferredLossesReleasedToInterestExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative instruments deferred losses released to interest expense.", "label": "Derivative Instruments Deferred Losses Released To Interest Expense", "terseLabel": "Derivative loss included in AOCI" } } }, "localname": "DerivativeInstrumentsDeferredLossesReleasedToInterestExpense", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DescriptionOfFloatingRateDerivativeActivities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of floating rate derivative activities.", "label": "Description Of Floating Rate Derivative Activities", "terseLabel": "Floating rate" } } }, "localname": "DescriptionOfFloatingRateDerivativeActivities", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "stringItemType" }, "ocdx_DollarTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dollar term loan facility.", "label": "Dollar Term Loan Facility [Member]", "terseLabel": "Dollar Term Loan Facility" } } }, "localname": "DollarTermLoanFacilityMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DueToRelatedPartiesCurrentAmountsOfTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due To Related Parties Current Amounts Of Transaction", "label": "Due To Related Parties Current Amounts Of Transaction", "terseLabel": "Due to related party" } } }, "localname": "DueToRelatedPartiesCurrentAmountsOfTransaction", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_EachFiscalQuarterEndingAfterJuneThirtyTwoThousandTwentyOneAndOnOrBeforeSeptemberThirtyTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Each fiscal quarter ending after June thirty, two thousand twenty one and on or before September thirty, two thousand twenty two [Member]", "label": "Each Fiscal Quarter Ending After June Thirty Two Thousand Twenty One And On Or Before September Thirty Two Thousand Twenty Two [Member]", "terseLabel": "Each Fiscal Quarter Ending After June Thirty Two Thousand Twenty One And On Or Before September Thirty Two Thousand Twenty Two" } } }, "localname": "EachFiscalQuarterEndingAfterJuneThirtyTwoThousandTwentyOneAndOnOrBeforeSeptemberThirtyTwoThousandTwentyTwoMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_EachFiscalQuarterEndingOnOrBeforeSeptemberThirtyTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Each fiscal quarter ending on or before September thirty two thousand twenty two.", "label": "Each Fiscal Quarter Ending On Or Before September Thirty Two Thousand Twenty Two [Member]", "terseLabel": "Each Fiscal Quarter Ending on or Prior to September 30, 2022" } } }, "localname": "EachFiscalQuarterEndingOnOrBeforeSeptemberThirtyTwoThousandTwentyTwoMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_EachFiscalQuarterEndingThereafterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Each fiscal quarter ending thereafter.", "label": "Each Fiscal Quarter Ending Thereafter [Member]", "terseLabel": "Each Fiscal Quarter Ending Thereafter" } } }, "localname": "EachFiscalQuarterEndingThereafterMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_EffectiveIncomeTaxRateReconciliationForeignExchangeGainLoss": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation foreign exchange gain/loss", "label": "Effective Income Tax Rate Reconciliation Foreign Exchange Gain Loss", "terseLabel": "Foreign exchange gain/loss" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignExchangeGainLoss", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ocdx_EffectiveIncomeTaxRateReconciliationIndemnificationIncome": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Indemnification income.", "label": "Effective Income Tax Rate Reconciliation Indemnification Income", "negatedLabel": "Indemnification income", "terseLabel": "Indemnification income" } } }, "localname": "EffectiveIncomeTaxRateReconciliationIndemnificationIncome", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ocdx_EffectiveIncomeTaxRateReconciliationWithholdingTax": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Withholding Tax.", "label": "Effective Income Tax Rate Reconciliation Withholding Tax", "terseLabel": "Withholding Tax" } } }, "localname": "EffectiveIncomeTaxRateReconciliationWithholdingTax", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ocdx_EmployeeBenefitsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee benefits.", "label": "Employee Benefits Policy [Text Block]", "terseLabel": "Employee Benefits" } } }, "localname": "EmployeeBenefitsPolicyTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ocdx_EmployeeRelatedObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee related obligations.", "label": "Employee Related Obligations", "terseLabel": "Employee related obligations" } } }, "localname": "EmployeeRelatedObligations", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_EquityInvestments": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity Investments", "label": "Equity Investments" } } }, "localname": "EquityInvestments", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_EuMedicalDeviceRegulationTransitionCost": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "EU medical device regulation transition cost", "label": "EU medical device regulation transition costs" } } }, "localname": "EuMedicalDeviceRegulationTransitionCost", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_EuroCurrencyRateLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro-currency rate loans.", "label": "Euro-Currency Rate Loans [Member]", "terseLabel": "Euro- Currency Rate Loans" } } }, "localname": "EuroCurrencyRateLoansMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_EuroTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro term loan facility.", "label": "Euro Term Loan Facility [Member]", "terseLabel": "Euro Term Loan Facility" } } }, "localname": "EuroTermLoanFacilityMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails" ], "xbrltype": "domainItemType" }, "ocdx_ExpectedNotionalValueTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected notional value two thousand twenty three.", "label": "Expected Notional Value Two Thousand Twenty Three [Member]", "terseLabel": "Expected Notional Value 2023" } } }, "localname": "ExpectedNotionalValueTwoThousandTwentyThreeMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "ocdx_ExpectedNotionalValueTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected notional value two thousand twenty two.", "label": "Expected Notional Value Two Thousand Twenty Two [Member]", "terseLabel": "Expected Notional Value 2022" } } }, "localname": "ExpectedNotionalValueTwoThousandTwentyTwoMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "ocdx_FairValueOfPlanAssetsForPensionPlans": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of plan assets for pension plans", "label": "Fair value of plan assets for pension plans", "terseLabel": "Fair Value of Plan Assets for Pension Plans" } } }, "localname": "FairValueOfPlanAssetsForPensionPlans", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "ocdx_FederalFundsRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal Funds Rate.", "label": "Federal Funds Rate", "terseLabel": "Federal funds rate" } } }, "localname": "FederalFundsRate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_FederalOperatingLlossCarryforwardsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Federal operating loss carryforwards net.", "label": "Federal Operating Lloss Carryforwards Net", "terseLabel": "Federal operating loss carryforwards net" } } }, "localname": "FederalOperatingLlossCarryforwardsNet", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_FederalOperatingLossCarryForwardExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal operating loss carryforward expiration year", "label": "Federal Operating Loss Carry Forward Expiration Year", "terseLabel": "Federal operating loss carryforwards expiry" } } }, "localname": "FederalOperatingLossCarryForwardExpirationYear", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "gYearItemType" }, "ocdx_FifthAmendmentOfCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifth amendment of credit agreement.", "label": "Fifth Amendment Of Credit Agreement [Member]", "terseLabel": "Fifth Amendment of Credit Agreement" } } }, "localname": "FifthAmendmentOfCreditAgreementMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_FirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien net leverage ratio.", "label": "First Lien Net Leverage Ratio", "terseLabel": "First Lien Net Leverage Ratio" } } }, "localname": "FirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "ocdx_FirstLienNetLeverageRatioMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien net leverage ratio maximum.", "label": "First Lien Net Leverage Ratio Maximum", "terseLabel": "First Lien Net Leverage Ratio Maximum" } } }, "localname": "FirstLienNetLeverageRatioMaximum", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "ocdx_FirstLienNetLeverageRatioMaximumPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien net leverage ratio maximum percentage.", "label": "First Lien Net Leverage Ratio Maximum Percentage", "terseLabel": "First Lien Net Leverage Ratio Maximum Percentage" } } }, "localname": "FirstLienNetLeverageRatioMaximumPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_FirstLienNetLeverageRatioMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien net leverage ratio minimum.", "label": "First Lien Net Leverage Ratio Minimum", "terseLabel": "First Lien Net Leverage Ratio Minimum" } } }, "localname": "FirstLienNetLeverageRatioMinimum", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "ocdx_FirstLienNetLeverageRatioMinimumPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien net leverage ratio minimum percentage.", "label": "First Lien Net Leverage Ratio Minimum Percentage", "terseLabel": "First Lien Net Leverage Ratio Minimum Percentage" } } }, "localname": "FirstLienNetLeverageRatioMinimumPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign-currency denominated debt.", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign Currency Denominated Debt" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "ocdx_GainLossOnCrossCurrencySwapsDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on cross currency swaps derivative instruments not designated as hedging instruments.", "label": "Gain Loss On Cross Currency Swaps Derivative Instruments Not Designated As Hedging Instruments", "terseLabel": "Cross currency swaps" } } }, "localname": "GainLossOnCrossCurrencySwapsDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_GeneralAndDescriptionOfBusinessLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General and description of business.", "label": "General And Description Of Business [Line Items]", "terseLabel": "General And Description Of Business [Line Items]" } } }, "localname": "GeneralAndDescriptionOfBusinessLineItems", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_GeneralAndDescriptionOfBusinessTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General and description of business.", "label": "General And Description Of Business [Table]", "terseLabel": "General And Description Of Business [Table]" } } }, "localname": "GeneralAndDescriptionOfBusinessTable", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_GovernmentGrantsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government grants.", "label": "Government Grants Policy [Text Block]", "terseLabel": "Government Grants" } } }, "localname": "GovernmentGrantsPolicyTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ocdx_GreaterChinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Greater China.", "label": "Greater China [Member]", "terseLabel": "Greater China" } } }, "localname": "GreaterChinaMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "ocdx_GrifolsDiagnosticSolutionsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grifols diagnostic solutions, Inc.", "label": "Grifols Diagnostic Solutions Inc [Member]", "terseLabel": "Grifols Diagnostic Solutions, Inc." } } }, "localname": "GrifolsDiagnosticSolutionsIncMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_HalfOfPercentageFederalFundsRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Half of percentage Federal Funds Rate.", "label": "Half of percentage Federal Funds Rate" } } }, "localname": "HalfOfPercentageFederalFundsRate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_HealthCareDiagnosticsCompaniesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care diagnostics companies", "label": "Health Care Diagnostics Companies [Member]", "terseLabel": "Health Care Diagnostics Companies" } } }, "localname": "HealthCareDiagnosticsCompaniesMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_HealthcareEquipmentCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare equipment company.", "label": "Healthcare Equipment Company [Member]", "terseLabel": "Healthcare Equipment Company" } } }, "localname": "HealthcareEquipmentCompanyMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ImpactFromAdoptionOfAccountingStandardsUpdate201712": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Impact from adoption of accounting standards update 2017-12.", "label": "Impact From Adoption Of Accounting Standards Update201712", "terseLabel": "Impact from adoption of ASU 2017-12" } } }, "localname": "ImpactFromAdoptionOfAccountingStandardsUpdate201712", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "ocdx_IncomeTaxExpensesOnPensionAndOtherPostemploymentBenefits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax expenses on pension and other postemployment benefits.", "label": "Income Tax Expenses On Pension And Other Postemployment Benefits", "terseLabel": "Income tax expenses on pension and other post employment benefits" } } }, "localname": "IncomeTaxExpensesOnPensionAndOtherPostemploymentBenefits", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical" ], "xbrltype": "monetaryItemType" }, "ocdx_IncreaseDecreaseInOtherCurrentAndNonCurrentAssets": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in other current and non-current assets.", "label": "Increase Decrease In Other Current And Non Current Assets", "negatedLabel": "Other current and non-current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAndNonCurrentAssets", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_IncreaseDecreaseInOtherCurrentAndNonCurrentLiabilities": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in other current and non-current liabilities.", "label": "Increase Decrease In Other Current And Non Current Liabilities", "terseLabel": "Other current and non-current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentAndNonCurrentLiabilities", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_IncreaseInInvestmentInSubsidiaries": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase in investment in subsidiaries", "label": "Increase in investment in subsidiaries", "negatedLabel": "Increase in investment in subsidiaries" } } }, "localname": "IncreaseInInvestmentInSubsidiaries", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_IndemnificationReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification receivable", "label": "Indemnification Receivable", "terseLabel": "Indemnification receivable" } } }, "localname": "IndemnificationReceivable", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_IndemnificationTaxThatWouldImpactEarningsLossBeforeProvisionForTaxesOnIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Indemnification tax that would impact earnings (loss) before provision for taxes on income.", "label": "Indemnification Tax That Would Impact Earnings Loss Before Provision For Taxes On Income", "terseLabel": "Indemnification Tax That Would Impact Earnings(loss) Before Provision For Taxes On Income" } } }, "localname": "IndemnificationTaxThatWouldImpactEarningsLossBeforeProvisionForTaxesOnIncome", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_IndemnityReceivables": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnity receivables.", "label": "Indemnity Receivables", "terseLabel": "Indemnity receivables" } } }, "localname": "IndemnityReceivables", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_IndirectTaxBenefit": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 6.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indirect tax benefit.", "label": "Indirect Tax Benefit", "terseLabel": "Indirect tax benefit" } } }, "localname": "IndirectTaxBenefit", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_InformationTechnologyCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information technology company.", "label": "Information Technology Company [Member]", "terseLabel": "Information Technology Company" } } }, "localname": "InformationTechnologyCompanyMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_InterestExpenseDebtNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest expense debt, net.", "label": "Interest Expense Debt Net Table [Text Block]", "terseLabel": "Schedule of Interest Expense, Net" } } }, "localname": "InterestExpenseDebtNetTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "ocdx_InterestRateDerivativeAgreementsEffectiveDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate derivative agreements effective date.", "label": "Interest Rate Derivative Agreements Effective Date", "terseLabel": "Effective date" } } }, "localname": "InterestRateDerivativeAgreementsEffectiveDate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "dateItemType" }, "ocdx_InterestRateDerivativeAgreementsExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate derivative agreements expiration date.", "label": "Interest Rate Derivative Agreements Expiration Date", "terseLabel": "Expiration date" } } }, "localname": "InterestRateDerivativeAgreementsExpirationDate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "dateItemType" }, "ocdx_InterestRateSwap1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate swap 1.", "label": "Interest Rate Swap1 [Member]", "terseLabel": "Interest Rate Swap1" } } }, "localname": "InterestRateSwap1Member", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "domainItemType" }, "ocdx_InterestRateSwapPreviouslyHedgedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate swap previously hedged.", "label": "Interest Rate Swap Previously Hedged [Member]", "terseLabel": "Interest Rate Swap Previously Hedged" } } }, "localname": "InterestRateSwapPreviouslyHedgedMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_InventoriesAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories acquired.", "label": "Inventories Acquired", "terseLabel": "Inventories, purchased", "verboseLabel": "Inventories, purchased" } } }, "localname": "InventoriesAcquired", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_InventoriesTransferedToPropertyPlantAndEquipmentNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventories transfered to Property, Plant and Equipment, Net.", "label": "Inventories Transfered To Property Plant And Equipment Net", "terseLabel": "Inventories transfered to Property, Plant and Equipment, Net" } } }, "localname": "InventoriesTransferedToPropertyPlantAndEquipmentNet", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_InvestmentsInSubsidiaries": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investments in subsidiaries.", "label": "Investments In Subsidiaries", "terseLabel": "Investments in subsidiaries" } } }, "localname": "InvestmentsInSubsidiaries", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_InvestmentsInSubsidiary": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments In Subsidiary", "label": "Investments In Subsidiary", "terseLabel": "Investments in subsidiaries" } } }, "localname": "InvestmentsInSubsidiary", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_JapaneseYenCrossCurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Japanese Yen Cross Currency Swap.", "label": "Japanese Yen Cross Currency Swap [Member]", "terseLabel": "Japanese Yen Cross Currency Swap" } } }, "localname": "JapaneseYenCrossCurrencySwapMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_JohnsonAndJohnsonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Johnson And Johnson", "label": "Johnson And Johnson [Member]", "terseLabel": "Johnson And Johnson [Member]" } } }, "localname": "JohnsonAndJohnsonMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_JointBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint business.", "label": "Joint Business [Member]", "terseLabel": "Joint Business" } } }, "localname": "JointBusinessMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails" ], "xbrltype": "domainItemType" }, "ocdx_LeaseReceivable": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 7.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lease Receivable", "label": "Lease Receivable", "terseLabel": "Lease receivable" } } }, "localname": "LeaseReceivable", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_LetterAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Letter agreement.", "label": "Letter Agreement [Member]", "terseLabel": "Letter Agreement" } } }, "localname": "LetterAgreementMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_LineOfCreditAmortizationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of credit amortization percentage.", "label": "Line Of Credit Amortization Percentage", "terseLabel": "Line of credit amortization percentage" } } }, "localname": "LineOfCreditAmortizationPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_LitigationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Litigation.", "label": "Litigation Policy [Text Block]", "terseLabel": "Litigation" } } }, "localname": "LitigationPolicyTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ocdx_LondonInterbankOfferedFloorRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LIBOR floor rate.", "label": "London Interbank Offered Floor Rate [Member]", "terseLabel": "London Interbank Offered Floor Rate" } } }, "localname": "LondonInterbankOfferedFloorRateMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ManagementAdjustmentsAndRealizedForeignExchangeLosses": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Management adjustments and realized foreign exchange losses.", "label": "Management Adjustments And Realized Foreign Exchange Losses", "terseLabel": "Management adjustments and realized foreign exchange losses" } } }, "localname": "ManagementAdjustmentsAndRealizedForeignExchangeLosses", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ManagementEarningsBeforeInterestTaxDepreciationAndAmortization": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Management earnings before interest tax depreciation and amortization.", "label": "Management Earnings Before Interest Tax Depreciation And Amortization", "terseLabel": "Management EBITDA" } } }, "localname": "ManagementEarningsBeforeInterestTaxDepreciationAndAmortization", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ManagementEarningsBeforeInterestTaxDepreciationAndAmortizationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Management Earnings Before Interest Tax Depreciation And Amortization [Text Block ]", "label": "Management Earnings Before Interest Tax Depreciation And Amortization [Text Block ]", "terseLabel": "Management EBITDA by Segment" } } }, "localname": "ManagementEarningsBeforeInterestTaxDepreciationAndAmortizationTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "ocdx_ManagementFeeAndOtherOutOfPocketExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Management fee and other out-of-pocket expenses.", "label": "Management Fee And Other Out Of Pocket Expenses", "terseLabel": "Management fee and other out-of-pocket expenses" } } }, "localname": "ManagementFeeAndOtherOutOfPocketExpenses", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_MandatoryPrepaymentOfDebtIssuancesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mandatory prepayment of debt issuances percentage.", "label": "Mandatory Prepayment Of Debt Issuances Percentage", "terseLabel": "Mandatory Prepayment of Debt Issuances Percentage" } } }, "localname": "MandatoryPrepaymentOfDebtIssuancesPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_MandatoryPrepaymentOfExcessCashFlowPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mandatory prepayment of excess cash flow percentage.", "label": "Mandatory Prepayment Of Excess Cash Flow Percentage", "terseLabel": "Mandatory Prepayment of Excess Cash Flow Percentage" } } }, "localname": "MandatoryPrepaymentOfExcessCashFlowPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_MandatoryPrepaymentOfNetCashProceedsOfAssetsSalesInExcess": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Mandatory prepayment of net cash proceeds of assets sales in excess.", "label": "Mandatory Prepayment Of Net Cash Proceeds Of Assets Sales In Excess", "terseLabel": "Mandatory Prepayment of Net Cash Proceeds of Assets Sales In Excess" } } }, "localname": "MandatoryPrepaymentOfNetCashProceedsOfAssetsSalesInExcess", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_MandatoryPrepaymentOfNetCashProceedsOfSalesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mandatory prepayment of net cash proceeds of sales percentage.", "label": "Mandatory Prepayment Of Net Cash Proceeds Of Sales Percentage", "terseLabel": "Mandatory Prepayment of Net Cash Proceeds of Sales Percentage" } } }, "localname": "MandatoryPrepaymentOfNetCashProceedsOfSalesPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_MandatoryPrepaymentOfSubjectToReinvestmentRights": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Mandatory prepayment of subject to reinvestment rights.", "label": "Mandatory Prepayment Of Subject To Reinvestment Rights", "terseLabel": "Mandatory prepayment of subject to reinvestment rights" } } }, "localname": "MandatoryPrepaymentOfSubjectToReinvestmentRights", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_MaximumAmountOfCommittedAmountForFirstLienNetLeverageRatio": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum amount of committed amount for first lien net leverage ratio.", "label": "Maximum Amount Of Committed Amount For First Lien Net Leverage Ratio", "terseLabel": "Maximum amount of committed amount for first lien net leverage ratio" } } }, "localname": "MaximumAmountOfCommittedAmountForFirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_MaximumAmountOfReceivableToBeSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum amount of receivable to be sold.", "label": "Maximum Amount Of Receivable To Be Sold", "terseLabel": "Maximum amount of receivable to be sold" } } }, "localname": "MaximumAmountOfReceivableToBeSold", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_MaximumPercentageOfCommittedAmountForFirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of committed amount for first lien net leverage ratio.", "label": "Maximum Percentage Of Committed Amount For First Lien Net Leverage Ratio", "terseLabel": "Maximum Percentage Of Committed Amount For First Lien Net Leverage Ratio" } } }, "localname": "MaximumPercentageOfCommittedAmountForFirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_MilestonePaymentsAndOtherNet": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Milestone payments and other, net.", "label": "Milestone Payments And Other Net", "terseLabel": "Milestone payments and other, net" } } }, "localname": "MilestonePaymentsAndOtherNet", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_MultiCurrencySublimitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-currency sublimit member.", "label": "Multi Currency Sublimit [Member]", "terseLabel": "Multi Currency Sublimit" } } }, "localname": "MultiCurrencySublimitMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_NetBenefitDueToIncreaseInInterestExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net Benefit Due to Increase In Interest Expenses", "label": "Net Benefit Due to Increase In Interest Expenses", "terseLabel": "Net Benefit Due to Increase In Interest Expenses" } } }, "localname": "NetBenefitDueToIncreaseInInterestExpenses", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NetIncomeLossShareInSubsidiary": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net income (loss) share in subsidiary.", "label": "Net Income Loss Share In Subsidiary", "negatedLabel": "Equity loss in subsidiaries", "terseLabel": "Equity in loss of subsidiaries" } } }, "localname": "NetIncomeLossShareInSubsidiary", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NetOperatingLossCarryforwardExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net operating loss carryforward expiration year.", "label": "Net Operating Loss Carryforward Expiration Year", "terseLabel": "Net operating loss carry forwards, expire period" } } }, "localname": "NetOperatingLossCarryforwardExpirationYear", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "gYearItemType" }, "ocdx_NetProfitSharedUnderJointVentureBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net profit shared under joint venture, before tax.", "label": "Net Profit Shared Under Joint Venture Before Tax", "terseLabel": "Net profit shared under joint venture, before tax" } } }, "localname": "NetProfitSharedUnderJointVentureBeforeTax", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NonRefundableUpfrontPayment": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 11.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-refundable upfront payment.", "label": "Non Refundable Upfront Payment", "negatedLabel": "Quotient upfront payment", "terseLabel": "Non-refundable upfront payment", "verboseLabel": "Quotient upfront payment" } } }, "localname": "NonRefundableUpfrontPayment", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_NoncashInvestingAndFinancingActivitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncash investing and financing activities.", "label": "Noncash Investing And Financing Activities [Text Block]", "terseLabel": "Noncash Investing And Financing Activities" } } }, "localname": "NoncashInvestingAndFinancingActivitiesTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureNoncashInvestingAndFinancingActivities" ], "xbrltype": "textBlockItemType" }, "ocdx_NoncashTransferOfInventoryToPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash transfer of inventory to property, plant and equipment.", "label": "Noncash Transfer Of Inventory To Property Plant And Equipment", "terseLabel": "Noncash transfer of inventory to property, plant and equipment, net" } } }, "localname": "NoncashTransferOfInventoryToPropertyPlantAndEquipment", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NoncurrentDeferredTaxAssetsGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncurrent Deferred Tax Assets Gross", "label": "Noncurrent Deferred Tax Assets Gross" } } }, "localname": "NoncurrentDeferredTaxAssetsGross", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NoncurrentDeferredTaxLiabilitiesGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncurrent Deferred Tax Liabilities Gross", "label": "Noncurrent Deferred Tax Liabilities Gross" } } }, "localname": "NoncurrentDeferredTaxLiabilitiesGross", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NondeductibleExecutiveCompensation": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 11.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Nondeductible executive compensation.", "label": "Nondeductible Executive Compensation", "negatedLabel": "Nondeductible executive compensation", "terseLabel": "Nondeductible executive compensation" } } }, "localname": "NondeductibleExecutiveCompensation", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "ocdx_NumberOfAwardsUnderCollaborationAndLicenseAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of awards under collaboration and license agreements.", "label": "Number Of Awards Under Collaboration And License Agreements", "terseLabel": "Number of awards under collaboration and license agreements" } } }, "localname": "NumberOfAwardsUnderCollaborationAndLicenseAgreements", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_NumberOfCollaborationAndLicenseAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of collaboration and license agreements.", "label": "Number Of Collaboration And License Agreements", "terseLabel": "Number of collaboration and license agreements" } } }, "localname": "NumberOfCollaborationAndLicenseAgreements", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_NumberOfCountriesAndTerritoriesWithCommercialPresence": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of countries and territories with commercial presence.", "label": "Number Of Countries And Territories With Commercial Presence", "terseLabel": "Number of countries and territories with commercial presence" } } }, "localname": "NumberOfCountriesAndTerritoriesWithCommercialPresence", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_NumberOfCountriesWithDirectCommercialPresence": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of countries with direct commercial presence.", "label": "Number Of Countries With Direct Commercial Presence", "terseLabel": "Number of countries with direct commercial presence" } } }, "localname": "NumberOfCountriesWithDirectCommercialPresence", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Customers", "label": "Number Of Customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_OfficeSpaceAndWarehouseSpaceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Space And Warehouse Space [Member]", "label": "Office Space And Warehouse Space [Member]", "terseLabel": "Office Space and Warehouse Space" } } }, "localname": "OfficeSpaceAndWarehouseSpaceMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_OrthoClinicalDiagnosticsHoldingLuxembourgSRLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ortho-Clinical Diagnostics Holdings Luxembourg S.\u00e0 r.l.", "label": "Ortho Clinical Diagnostics Holding Luxembourg S R L [Member]", "terseLabel": "Ortho-Clinical Diagnostics Holdings Luxembourg S.\u00e0 r.l" } } }, "localname": "OrthoClinicalDiagnosticsHoldingLuxembourgSRLMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_OrthoClinicalDiagnosticsSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ortho-Clinical Diagnostics S.A.", "label": "Ortho Clinical Diagnostics S A [Member]", "terseLabel": "Ortho-Clinical Diagnostics S.A." } } }, "localname": "OrthoClinicalDiagnosticsSAMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_OtherAdjustments": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 12.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other adjustments.", "label": "Other Adjustments", "negatedLabel": "Other adjustments", "terseLabel": "Other adjustments" } } }, "localname": "OtherAdjustments", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherAsset": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 10.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other asset.", "label": "Other Asset", "terseLabel": "Other" } } }, "localname": "OtherAsset", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherComprehensiveIncomeLossDefinedBenefitPlanAmortizationOfGainLoss": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 2.0, "parentTag": "ocdx_DefinedBenefitPlanIncomeLossRecognizedInOtherComprehensiveLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Amortization of gain (loss).", "label": "Other Comprehensive Income Loss Defined Benefit Plan Amortization Of Gain Loss", "terseLabel": "Amortization of gain (loss)" } } }, "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanAmortizationOfGainLoss", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherComprehensiveIncomeLossDefinedBenefitPlanAmortizationOfPriorServiceCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Amortization of prior service cost.", "label": "Other Comprehensive Income Loss Defined Benefit Plan Amortization Of Prior Service Cost", "terseLabel": "Amortization of prior service cost" } } }, "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanAmortizationOfPriorServiceCost", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherComprehensiveIncomeLossDefinedBenefitPlanNetActuarialLossGain": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 0.0, "parentTag": "ocdx_DefinedBenefitPlanIncomeLossRecognizedInOtherComprehensiveLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Net actuarial loss (gain).", "label": "Other Comprehensive Income Loss Defined Benefit Plan Net Actuarial Loss Gain", "terseLabel": "Net actuarial (gain) loss" } } }, "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanNetActuarialLossGain", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherComprehensiveIncomeLossDefinedBenefitPlanNetTranslationAdjustment": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 1.0, "parentTag": "ocdx_DefinedBenefitPlanIncomeLossRecognizedInOtherComprehensiveLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Net translation adjustment.", "label": "Other Comprehensive Income Loss Defined Benefit Plan Net Translation Adjustment", "terseLabel": "Net translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanNetTranslationAdjustment", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherCountriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other countries member.", "label": "Other Countries [Member]", "terseLabel": "Other" } } }, "localname": "OtherCountriesMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails" ], "xbrltype": "domainItemType" }, "ocdx_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other.", "label": "Other [Member]", "terseLabel": "Other" } } }, "localname": "OtherMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "domainItemType" }, "ocdx_OtherPostemploymentBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other postemployment benefit plan assumptions used calculating net periodic benefit cost discount rate.", "label": "Other Postemployment Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate", "terseLabel": "Discount rate to determine net cost" } } }, "localname": "OtherPostemploymentBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "percentItemType" }, "ocdx_OtherPostemploymentBenefitPlansAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other postemployment benefit plans assumptions used calculating benefit obligation discount rate.", "label": "Other Postemployment Benefit Plans Assumptions Used Calculating Benefit Obligation Discount Rate", "terseLabel": "Discount rate to determine benefit obligations" } } }, "localname": "OtherPostemploymentBenefitPlansAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "percentItemType" }, "ocdx_OtherPostemploymentBenefitPlansExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other postemployment benefit plans expected benefit payments fiscal years thereafter.", "label": "Other Postemployment Benefit Plans Expected Future Benefit Payments Five Fiscal Years Thereafter", "terseLabel": "Fiscal Year 2027-2031" } } }, "localname": "OtherPostemploymentBenefitPlansExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherPostemploymentBenefitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Postemployment Benefits.", "label": "Other Postemployment Benefits [Abstract]", "terseLabel": "Other Postemployment Benefits" } } }, "localname": "OtherPostemploymentBenefitsAbstract", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsSummaryOfPretaxAmountsOfNetPeriodicBenefitCostDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "stringItemType" }, "ocdx_OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other postemployment benefits plan expected future benefit payment , year five", "label": "Other Postemployment Benefits Plan Expected Future Benefit Payment Year Five", "terseLabel": "Fiscal Year 2026" } } }, "localname": "OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearFive", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other postemployment benefits plan expected future benefit payment , Year four", "label": "Other Postemployment Benefits Plan Expected Future Benefit Payment Year Four", "terseLabel": "Fiscal Year 2025" } } }, "localname": "OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearFour", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other postemployment benefits plan expected future benefit payment , year Three", "label": "Other Postemployment Benefits Plan Expected Future Benefit Payment Year Three", "terseLabel": "Fiscal Year 2024" } } }, "localname": "OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearThree", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other postemployment benefits plan expected future benefit payment , year two.", "label": "Other Postemployment Benefits Plan Expected Future Benefit Payment Year Two", "terseLabel": "Fiscal Year 2023" } } }, "localname": "OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentYearTwo", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other postemployment benefits plan expected future benefit payments next twelve months", "label": "Other Postemployment Benefits Plan Expected Future Benefit Payments Next Twelve Months", "terseLabel": "Fiscal Year 2022" } } }, "localname": "OtherPostemploymentBenefitsPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OutstandingBorrowingsInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Outstanding borrowings interest rate.", "label": "Outstanding borrowings interest rate" } } }, "localname": "OutstandingBorrowingsInterestRate", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_PayableToSubsidiary": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable to subsidiary.", "label": "Payable To Subsidiary", "terseLabel": "Payables to subsidiaries" } } }, "localname": "PayableToSubsidiary", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PaymentsUponAchievementOfCertainMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments upon achievement of certain milestones.", "label": "Payments Upon Achievement Of Certain Milestones", "terseLabel": "Payments upon achievement of certain milestones" } } }, "localname": "PaymentsUponAchievementOfCertainMilestones", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PercentageOfDebtBorrowingBaseRateOnAccountReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of debt borrowing base rate on account receivable.", "label": "Percentage Of Debt Borrowing Base Rate On Account Receivable", "terseLabel": "Percentage of Debt Borrowing Base Rate on Account Receivable" } } }, "localname": "PercentageOfDebtBorrowingBaseRateOnAccountReceivable", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_PercentageOfRestrictedNetAssetsOfSubsidiaries": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of restricted net assets of subsidiaries.", "label": "Percentage of Restricted Net Assets of Subsidiaries", "verboseLabel": "Percentage of restricted net assets of subsidiaries" } } }, "localname": "PercentageOfRestrictedNetAssetsOfSubsidiaries", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_PercentageOfRevenueRepresentingFixedLeaseRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of revenue representing fixed lease revenue.", "label": "Percentage of Revenue Representing Fixed Lease Revenue", "terseLabel": "Fixed lease revenue" } } }, "localname": "PercentageOfRevenueRepresentingFixedLeaseRevenue", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_PercentageOfRevenueRepresentingVariableLeaseRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of revenue representing variable lease revenue.", "label": "Percentage of Revenue Representing Variable Lease Revenue", "terseLabel": "Variable lease revenue" } } }, "localname": "PercentageOfRevenueRepresentingVariableLeaseRevenue", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_PercentageOfSharesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Shares acquired.", "label": "Percentage Of Shares Acquired", "terseLabel": "Percentage Of Shares Acquired" } } }, "localname": "PercentageOfSharesAcquired", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_PharmacyBenefitManagementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pharmacy Benefit Management [Member]", "label": "Pharmacy Benefit Management [Member]", "terseLabel": "Pharmacy Benefit Management" } } }, "localname": "PharmacyBenefitManagementMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_PharmacyRelatedServicesFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Pharmacy related services fee.", "label": "Pharmacy Related Services Fee", "terseLabel": "Pharmacy related services, fees" } } }, "localname": "PharmacyRelatedServicesFee", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PotentialAdditionalPaymentsUponAchievementOfCertainRegulatoryMilestonesAndCommercialSalesBenchmarks": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Potential additional payments upon achievement of certain regulatory milestones and commercial sales benchmarks.", "label": "Potential Additional Payments Upon Achievement Of Certain Regulatory Milestones And Commercial Sales Benchmarks", "terseLabel": "Potential additional payments upon achievement of certain regulatory milestones and commercial sales benchmarks" } } }, "localname": "PotentialAdditionalPaymentsUponAchievementOfCertainRegulatoryMilestonesAndCommercialSalesBenchmarks", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAndFiveOneZeroKApplicationsOfCOVIDNineteenTests": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Potential payment receivable for development and submission of emergency use authorizations and five one zero k applications of COVID nineteen tests.", "label": "Potential Payment Receivable For Development And Submission Of Emergency Use Authorizations And Five One Zero K Applications Of C O V I D Nineteen Tests", "terseLabel": "Potential payment receivable for development and submission of emergency use authorizations and 510(k) applications of COVID-19 tests" } } }, "localname": "PotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAndFiveOneZeroKApplicationsOfCOVIDNineteenTests", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PotentialPaymentsUponAchievementOfCertainCumulativeRevenueMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Potential payments upon achievement of certain cumulative revenue milestones.", "label": "Potential Payments Upon Achievement Of Certain Cumulative Revenue Milestones", "terseLabel": "Investment in Quotient", "verboseLabel": "Potential Payments Upon Achievement Of Certain Cumulative Revenue Milestones" } } }, "localname": "PotentialPaymentsUponAchievementOfCertainCumulativeRevenueMilestones", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_PreTaxNetProfitWhereCompanyIsPrincipal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents pre-tax net profits under the Joint Business on sales transactions where the Company is the principal.", "label": "Pre Tax Net Profit Where Company is Principal", "terseLabel": "Pre-tax net profit" } } }, "localname": "PreTaxNetProfitWhereCompanyIsPrincipal", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PreTaxRestructuringCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Pre tax restructuring costs.", "label": "Pre Tax Restructuring Costs", "terseLabel": "Pre tax restructuring costs" } } }, "localname": "PreTaxRestructuringCosts", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ProceedsFromCrossCurrencySwaps": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from cross currency swaps.", "label": "Proceeds From Cross Currency Swaps", "terseLabel": "Proceeds from cross-currency swaps" } } }, "localname": "ProceedsFromCrossCurrencySwaps", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_PropertyPlantEquipmentAndAccumulatedDepreciationBalancesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular Disclosure of Property, Plant, Equipment and Accumulated Depreciation Balances.", "label": "Property, Plant, Equipment and Accumulated Depreciation Balances Table Text Block", "terseLabel": "Schedule of Property, Plant, Equipment and Accumulated Depreciation Balances." } } }, "localname": "PropertyPlantEquipmentAndAccumulatedDepreciationBalancesTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentNetTable" ], "xbrltype": "textBlockItemType" }, "ocdx_PurchasesOfPropertyPlantAndEquipmentAndCapitalizedInternalUseSoftwareCostsIncludedInAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchases of property, plant and equipment and capitalized internal-use software costs included in accounts payable and accrued liabilities.", "label": "Purchases Of Property Plant And Equipment And Capitalized Internal Use Software Costs Included In Accounts Payable And Accrued Liabilities", "terseLabel": "Purchases of property, plant and equipment and capitalized internal-use software costs included in Accounts payable and Accrued liabilities" } } }, "localname": "PurchasesOfPropertyPlantAndEquipmentAndCapitalizedInternalUseSoftwareCostsIncludedInAccountsPayableAndAccruedLiabilities", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_QuidelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quidel Member", "label": "Quidel [Member]", "verboseLabel": "Quidel" } } }, "localname": "QuidelMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_QuotientLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quotient limited.", "label": "Quotient Limited [Member]", "terseLabel": "Quotient Limited" } } }, "localname": "QuotientLimitedMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "ocdx_RateOfLongTermReturnOnPlanAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rate of long term return on plan assets.", "label": "Rate Of Long Term Return On Plan Assets", "terseLabel": "Rate Of Long Term Return On Plan Assets" } } }, "localname": "RateOfLongTermReturnOnPlanAssets", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_RebateReserves": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rebate reserves.", "label": "Rebate Reserves", "periodEndLabel": "Balance at end of fiscal year", "periodStartLabel": "Balance at beginning of fiscal year" } } }, "localname": "RebateReserves", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRevenueSummaryOfChangesToRebateReservesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_RebateReservesAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Rebate reserves additions.", "label": "Rebate Reserves Additions", "terseLabel": "Additions" } } }, "localname": "RebateReservesAdditions", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRevenueSummaryOfChangesToRebateReservesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_RebateReservesDeduction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rebate reserves deduction.", "label": "Rebate Reserves Deduction", "terseLabel": "Deductions(a)" } } }, "localname": "RebateReservesDeduction", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRevenueSummaryOfChangesToRebateReservesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ReceivablesFromSubsidiaries": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivables from subsidiaries.", "label": "Receivables From Subsidiaries", "terseLabel": "Receivables from subsidiaries" } } }, "localname": "ReceivablesFromSubsidiaries", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ReceivablesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables purchase agreement.", "label": "Receivables Purchase Agreement [Member]", "terseLabel": "Receivables Purchase Agreement" } } }, "localname": "ReceivablesPurchaseAgreementMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_RedemptionOptionPercentageOfPrincipalAmountOfDebtWithNetCashProceedsOfEquityOfferings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption option percentage of principal amount of debt with net cash proceeds of equity offerings.", "label": "Redemption Option Percentage Of Principal Amount Of Debt With Net Cash Proceeds Of Equity Offerings", "terseLabel": "Percentage of principal amount of debt with net cash proceeds of equity offerings" } } }, "localname": "RedemptionOptionPercentageOfPrincipalAmountOfDebtWithNetCashProceedsOfEquityOfferings", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_ReportableSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reportable Segment.", "label": "Reportable Segment [Member]", "terseLabel": "Reportable Segment" } } }, "localname": "ReportableSegmentMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "ocdx_RestrictedStockSharesVestedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock, shares vested net of shares for tax withholdings", "label": "Restricted Stock Shares Vested Net Of Shares For Tax Withholdings", "terseLabel": "Restricted stock grant, net of shares retained for taxes, shares" } } }, "localname": "RestrictedStockSharesVestedNetOfSharesForTaxWithholdings", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "ocdx_RestructuringExpensesCumulativeCapitalExpenditure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Restructuring expenses cumulative capital expenditure.", "label": "Restructuring Expenses Cumulative Capital Expenditure", "verboseLabel": "Restructuring expenses cumulative capital expenditure" } } }, "localname": "RestructuringExpensesCumulativeCapitalExpenditure", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_RestructuringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restructuring member.", "label": "Restructuring [Member]", "terseLabel": "Restructuring" } } }, "localname": "RestructuringMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "domainItemType" }, "ocdx_RetirementBenefitObligationAmortizationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Retirement Benefit Obligation Amortization Term.", "label": "Retirement Benefit Obligation Amortization Term", "terseLabel": "Retirement benefit obligation , amortization term" } } }, "localname": "RetirementBenefitObligationAmortizationTerm", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ocdx_RevenueEarnedFromOperatingLeasesRecognizedPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Earned From Operating Leases Recognized Period", "label": "Revenue Earned From Operating Leases Recognized Period", "verboseLabel": "Revenue earned from operating leases recognized period" } } }, "localname": "RevenueEarnedFromOperatingLeasesRecognizedPeriod", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ocdx_RightOfUseOfAssets": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 0.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right of use of assets.", "label": "Right Of Use Of Assets", "terseLabel": "Right-of-use asset" } } }, "localname": "RightOfUseOfAssets", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfSupplementalBalanceSheetInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_SaleAndLeasebackFinancingArrangementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing arrangement period.", "label": "Sale And Leaseback Financing Arrangement Period", "terseLabel": "Financing period" } } }, "localname": "SaleAndLeasebackFinancingArrangementPeriod", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ocdx_SaleAndLeasebackFinancingAssetsSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing assets sold.", "label": "Sale And Leaseback Financing Assets Sold", "terseLabel": "Sale And Leaseback Financing Assets Sold" } } }, "localname": "SaleAndLeasebackFinancingAssetsSold", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_SaleAndLeasebackFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing.", "label": "Sale And Leaseback Financing [Member]", "terseLabel": "Sale and Leaseback Financing" } } }, "localname": "SaleAndLeasebackFinancingMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails" ], "xbrltype": "domainItemType" }, "ocdx_SaleAndLeasebackFinancingObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing obligation.", "label": "Sale And Leaseback Financing Obligation", "terseLabel": "Financing obligation" } } }, "localname": "SaleAndLeasebackFinancingObligation", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_SalesRecordedUnderAgreement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sales Recorded Under Agreement", "label": "Sales Recorded Under Agreement", "terseLabel": "Sales to Quotient" } } }, "localname": "SalesRecordedUnderAgreement", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ScheduleOfComponentsOfNetPeriodicBenefitCost": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Components Of Net Periodic Benefit Cost.", "label": "Schedule Of Components Of Net Periodic Benefit Cost", "terseLabel": "Components of Net Periodic Benefit Cost" } } }, "localname": "ScheduleOfComponentsOfNetPeriodicBenefitCost", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "ocdx_ScheduleOfForeignCurrencyForwardContractsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of Schedule of foreign currency forward contracts outstanding.", "label": "Schedule Of Foreign Currency Forward Contracts Outstanding [Table Text Block]", "terseLabel": "Schedule of Currency Hedging Instruments Outstanding" } } }, "localname": "ScheduleOfForeignCurrencyForwardContractsOutstandingTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "ocdx_ScheduleOfOtherDerivativesDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Other Derivatives Designated As Hedging Instruments Statements Of Financial Performance And Financial Position Location [Table Text Block].", "label": "Schedule Of Other Derivatives Designated As Hedging Instruments Statements Of Financial Performance And Financial Position Location Table [Text Block]", "terseLabel": "Derivatives Designated as Hedging Instruments" } } }, "localname": "ScheduleOfOtherDerivativesDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "ocdx_ScheduleOfRestructuringAndRelatedReserveTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of restructuring and related costs", "label": "Schedule Of Restructuring And Related Reserve Table [Text Block]", "terseLabel": "Restructuring And Related Reserve" } } }, "localname": "ScheduleOfRestructuringAndRelatedReserveTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsTable" ], "xbrltype": "textBlockItemType" }, "ocdx_SecondaryPublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Secondary public offering", "label": "Secondary Public Offering [Member]", "terseLabel": "Secondary Public Offering" } } }, "localname": "SecondaryPublicOfferingMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_SecurityServicesCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security Services Company [Member]", "label": "Security Services Company [Member]", "terseLabel": "Security Services Company" } } }, "localname": "SecurityServicesCompanyMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_SecurityServicesExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Security Services Expense", "label": "Security Services Expense", "terseLabel": "Security service expense" } } }, "localname": "SecurityServicesExpense", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_SeniorSecuredCreditFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured credit facilities.", "label": "Senior Secured Credit Facilities [Member]", "terseLabel": "Senior Secured Credit Facilities" } } }, "localname": "SeniorSecuredCreditFacilitiesMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ServiceCostForDefinedBenefitPlans": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Service cost for defined benefit plans", "label": "Service cost for defined benefit plans", "terseLabel": "Service Cost" } } }, "localname": "ServiceCostForDefinedBenefitPlans", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ServiceCostForOtherPostEmploymentBenefits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Service cost for other post employment benefits.", "label": "Service Cost for Other Post Employment Benefits", "verboseLabel": "Service cost" } } }, "localname": "ServiceCostForOtherPostEmploymentBenefits", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_SevenPointThreeSevenFivePercentSeniorNotesDueTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seven point three seven five percent senior notes due two thousand twenty five.", "label": "Seven Point Three Seven Five Percent Senior Notes Due Two Thousand Twenty Five [Member]", "terseLabel": "2025 Notes", "verboseLabel": "2025 Notes" } } }, "localname": "SevenPointThreeSevenFivePercentSeniorNotesDueTwoThousandTwentyFiveMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_SevenPointTwoFiveZeroPercentSeniorNotesDueTwoThousandTwentyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seven point two five zero percent senior notes due two thousand twenty eight notes.", "label": "Seven Point Two Five Zero Percent Senior Notes Due Two Thousand Twenty Eight [Member]", "terseLabel": "2028 Notes", "verboseLabel": "2028 Notes" } } }, "localname": "SevenPointTwoFiveZeroPercentSeniorNotesDueTwoThousandTwentyEightMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_SeveranceAndOtherCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Severance and other costs.", "label": "Severance and Other Costs", "terseLabel": "Severance and other costs" } } }, "localname": "SeveranceAndOtherCosts", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingRightsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award award remaining vesting rights percentage.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Rights Percentage", "terseLabel": "Remaining percentage of vesting award" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingRightsPercentage", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_ShareBasedCompensationWeightedAverageGrantDateFairValueExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation weighted average grant date fair value, exercisable", "label": "Share based compensation weighted average grant date fair value, exercisable", "terseLabel": "Exercisable as of January 2, 2022" } } }, "localname": "ShareBasedCompensationWeightedAverageGrantDateFairValueExercisable", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "ocdx_ShareBasedCompensationWeightedAverageGrantDateFairValueExpectedToVest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation weighted average grant date fair value, expected to vest", "label": "Share based compensation weighted average grant date fair value, expected to vest", "terseLabel": "Expected to vest as of January 2, 2022" } } }, "localname": "ShareBasedCompensationWeightedAverageGrantDateFairValueExpectedToVest", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "ocdx_ShareBasedCompensationWeightedAverageGrantDateFairValueTotalVestedAndExpectedToVest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation weighted average grant date fair value, total vested and expected to vest", "label": "Share based compensation weighted average grant date fair value, total vested and expected to vest", "terseLabel": "Total vested and expected to vest as of January 2, 2022", "totalLabel": "Total vested and expected to vest as of January 2, 2022" } } }, "localname": "ShareBasedCompensationWeightedAverageGrantDateFairValueTotalVestedAndExpectedToVest", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "ocdx_ShippingAndHandlingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shipping And Handling Cost Policy Text Block", "label": "Shipping And Handling Costs Policy Text Block", "terseLabel": "Shipping And Handling" } } }, "localname": "ShippingAndHandlingCostsPolicyTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "ocdx_SixPointSixTwoFivePercentSeniorNotesDueTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Six point six two five percent senior notes due two thousand twenty two.", "label": "Six Point Six Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member]", "terseLabel": "2022 Notes" } } }, "localname": "SixPointSixTwoFivePercentSeniorNotesDueTwoThousandTwentyTwoMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ocdx_StateNetOperatingLossCarryForwardExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "State net operating loss carry forward expiration year.", "label": "State Net Operating Loss Carry Forward Expiration Year", "terseLabel": "State operating loss carryforwards expiry" } } }, "localname": "StateNetOperatingLossCarryForwardExpirationYear", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "gYearItemType" }, "ocdx_SummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular Disclosure of cash flow Information, lease term and discount rate of operating lease.", "label": "Summary of Cash Flow Information, Lease Term And Discount Rate of Operating Lease Table Text Block", "terseLabel": "Summary of Cash Flow Information, Lease Term And Discount Rate of Operating Lease" } } }, "localname": "SummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "ocdx_SummaryOfIncomeStatementPresentationForCollaborationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of income statement presentation for collaboration (Table text Block)", "label": "Summary of income statement presentation for collaboration (Table text Block)", "terseLabel": "Summary of Income Statement Presentation For Collaboration" } } }, "localname": "SummaryOfIncomeStatementPresentationForCollaborationTableTextBlock", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "ocdx_TaxIndemnificationIncomeNet": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax indemnification income, net.", "label": "Tax Indemnification Income Net", "negatedLabel": "Tax indemnification expense", "terseLabel": "Tax indemnification (income) expense, net", "verboseLabel": "Tax indemnification expense, net" } } }, "localname": "TaxIndemnificationIncomeNet", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "ocdx_TechnologyServicesFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Technology services fee..", "label": "Technology Services Fee", "terseLabel": "IT service fees" } } }, "localname": "TechnologyServicesFee", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_TerminationFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Termination Fee", "label": "Termination Fee", "terseLabel": "Termination Fee" } } }, "localname": "TerminationFee", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_TimeBasedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time-Based Stock Options [Member].", "label": "Time Based Stock Options [Member]", "terseLabel": "Time Based Stock Options" } } }, "localname": "TimeBasedStockOptionsMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_TransfusionMedicineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfusion medicine.", "label": "Transfusion Medicine [Member]", "terseLabel": "Transfusion Medicine" } } }, "localname": "TransfusionMedicineMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "ocdx_TwoThousandAndFortyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand and Forty.", "label": "Two Thousand and Forty [Member]", "terseLabel": "2040 expiration year [Member]" } } }, "localname": "TwoThousandAndFortyMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_TwoThousandEighteenRestructuringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand eighteen restructuring member.", "label": "Two Thousand Eighteen Restructuring [Member]", "terseLabel": "2018 Restructuring" } } }, "localname": "TwoThousandEighteenRestructuringMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "domainItemType" }, "ocdx_TwoThousandFourteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2014 Plan", "label": "Two Thousand Fourteen Equity Incentive Plan [Member]", "terseLabel": "2014 Plan" } } }, "localname": "TwoThousandFourteenEquityIncentivePlanMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_TwoThousandFourteenPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Fourteen Plan [Member]", "label": "Two Thousand Fourteen Plan [Member]", "terseLabel": "2014 Plan [Member]" } } }, "localname": "TwoThousandFourteenPlanMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "domainItemType" }, "ocdx_TwoThousandSixteenRestructuringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand sixteen restructuring member.", "label": "Two Thousand Sixteen Restructuring [Member]", "terseLabel": "2016 Restructuring" } } }, "localname": "TwoThousandSixteenRestructuringMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "domainItemType" }, "ocdx_TwoThousandTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Twenty One Plan Member", "label": "Two Thousand Twenty One Plan [Member]", "verboseLabel": "2021 Plan" } } }, "localname": "TwoThousandTwentyOnePlanMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_UKHoldcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "UK Holdco.", "label": "U K Holdco [Member]", "terseLabel": "UK Holdco" } } }, "localname": "UKHoldcoMember", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_UnrealizedForeignCurrencyTransactionGainLossRemeasurement": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 10.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrealized foreign currency transaction gain loss remeasurement.", "label": "Unrealized Foreign Currency Transaction Gain Loss Remeasurement", "negatedLabel": "Unrealized foreign currency exchanges losses, net", "negatedTerseLabel": "Unrealized foreign currency exchange (losses) gains, net", "terseLabel": "Unrealized foreign currency exchange losses (gains)" } } }, "localname": "UnrealizedForeignCurrencyTransactionGainLossRemeasurement", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "ocdx_UnrecognizedTaxBenefitsIncludingInterestAndPenalties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrecognized tax benefits including interest and penalties", "label": "Unrecognized tax benefits including interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncludingInterestAndPenalties", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_WeightedAverageRemainingContractualTermExpectedToVest": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term, expected to vest", "label": "Weighted average remaining contractual term, expected to vest", "terseLabel": "Expected to vest as of January 2, 2022" } } }, "localname": "WeightedAverageRemainingContractualTermExpectedToVest", "nsuri": "http://orthoclinical.com/20220102", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continents of North and South America.", "label": "Americas [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "srt_CondensedBalanceSheetStatementTable": { "auth_ref": [ "r151", "r606", "r843" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet Statement [Table]", "terseLabel": "Condensed Balance Sheet Statement [Table]" } } }, "localname": "CondensedBalanceSheetStatementTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "srt_CondensedBalanceSheetStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Balance Sheet Statements Captions [Line Items]", "terseLabel": "Condensed Balance Sheet Statements Captions [Line Items]" } } }, "localname": "CondensedBalanceSheetStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "srt_CondensedCashFlowStatementTable": { "auth_ref": [ "r151", "r606", "r852" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.", "label": "Condensed Cash Flow Statement [Table]", "terseLabel": "Condensed Cash Flow Statement [Table]" } } }, "localname": "CondensedCashFlowStatementTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedCashFlowStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Cash Flow Statements Captions [Line Items]", "terseLabel": "Condensed Cash Flow Statements Captions [Line Items]" } } }, "localname": "CondensedCashFlowStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Financial Information Of Parent Company Only Disclosure [Abstract]" } } }, "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract", "nsuri": "http://fasb.org/srt/2021-01-31", "xbrltype": "stringItemType" }, "srt_CondensedStatementOfComprehensiveIncomeTable": { "auth_ref": [ "r151", "r606", "r843" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.", "label": "Condensed Statement Of Comprehensive Income [Table]", "terseLabel": "Condensed Statement Of Comprehensive Income [Table]" } } }, "localname": "CondensedStatementOfComprehensiveIncomeTable", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.", "label": "Condensed Statement Of Comprehensive Income Table [Text Block]", "terseLabel": "Schedule of Condensed Statement of Comprehensive Income" } } }, "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyTables" ], "xbrltype": "textBlockItemType" }, "srt_CondensedStatementOfIncomeCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Statement Of Income Captions [Line Items]", "terseLabel": "Condensed Statement Of Income Captions [Line Items]" } } }, "localname": "CondensedStatementOfIncomeCaptionsLineItems", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r151", "r301", "r306", "r314", "r608", "r609", "r614", "r615", "r717", "r825", "r841", "r853", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Information by consolidated entity or group of entities.", "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r151", "r301", "r306", "r314", "r608", "r609", "r614", "r615", "r717", "r825", "r841", "r853", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Entity or group of entities consolidated into reporting entity.", "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r151", "r200", "r213", "r214", "r215", "r216", "r218", "r220", "r224", "r301", "r302", "r303", "r304", "r305", "r306", "r308", "r309", "r311", "r313", "r314", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r151", "r200", "r213", "r214", "r215", "r216", "r218", "r220", "r224", "r301", "r302", "r303", "r304", "r305", "r306", "r308", "r309", "r311", "r313", "r314", "r853", "r854", "r855", "r856", "r857", "r858", "r859", "r860", "r861", "r862", "r863" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r73", "r75", "r149", "r150", "r320", "r359", "r865" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r232", "r393", "r399", "r797" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r319", "r358", "r488", "r494", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r794", "r798", "r826", "r827" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r319", "r358", "r488", "r494", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r794", "r798", "r826", "r827" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "auth_ref": [ "r807", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r840", "r842" ], "lang": { "en-us": { "role": { "documentation": "Information by type of real estate property.", "label": "Real Estate, Type of Property [Axis]" } } }, "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "auth_ref": [ "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r840", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851" ], "lang": { "en-us": { "role": { "documentation": "Land and any structures permanently fixed to it.", "label": "Real Estate [Domain]" } } }, "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r232", "r393", "r399", "r797" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_OfficeBuildingMember": { "auth_ref": [ "r807", "r824", "r840", "r842" ], "lang": { "en-us": { "role": { "documentation": "Building designed primarily for the conduct of business, for example, but not limited to, administration, clerical services, and consultation.", "label": "Office Building [Member]", "terseLabel": "Office Space" } } }, "localname": "OfficeBuildingMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Axis]", "terseLabel": "Ownership" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment.", "label": "Ownership [Domain]", "terseLabel": "Ownership" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ParentCompanyMember": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "The registrant that controls, directly or indirectly, another entity (or entities). The usual condition for control is ownership of a majority (over 50%) of the outstanding voting stock. The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders or by court decree.", "label": "Parent Company [Member]", "terseLabel": "Parent Company" } } }, "localname": "ParentCompanyMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r227", "r393", "r397", "r734", "r793", "r795" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product Or Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r227", "r393", "r397", "r734", "r793", "r795" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Products And Services [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r319", "r358", "r435", "r488", "r494", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r794", "r798", "r826", "r827" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r319", "r358", "r435", "r488", "r494", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r794", "r798", "r826", "r827" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r74", "r75", "r149", "r150", "r320", "r359" ], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r161", "r489", "r839" ], "lang": { "en-us": { "role": { "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.", "label": "Scenario Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r161", "r165", "r489" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario Unspecified [Domain]", "terseLabel": "Scenario" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Schedule Of Condensed Balance Sheet Table [Text Block]", "terseLabel": "Schedule of Condensed Balance Sheet" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfCondensedCashFlowStatementTableTextBlock": { "auth_ref": [ "r864" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.", "label": "Schedule Of Condensed Cash Flow Statement Table [Text Block]", "terseLabel": "Schedule of Condensed Cash Flow Statement" } } }, "localname": "ScheduleOfCondensedCashFlowStatementTableTextBlock", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyTables" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r228", "r229", "r393", "r398", "r796", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r840", "r844", "r845", "r846", "r847", "r848", "r849", "r850", "r851" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r228", "r229", "r393", "r398", "r796", "r807", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r840", "r842" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r161", "r165", "r295", "r489", "r721" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Statement Scenario [Axis]", "terseLabel": "Scenario" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_WarehouseMember": { "auth_ref": [ "r807", "r824", "r840", "r842" ], "lang": { "en-us": { "role": { "documentation": "Facility designed for the storage of goods or equipment.", "label": "Warehouse [Member]", "terseLabel": "Warehouse Space" } } }, "localname": "WarehouseMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable And Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r49", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable", "totalLabel": "Accounts Payable, Current, Total" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r811" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r7", "r30", "r234", "r235" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Net Current", "terseLabel": "Accounts receivable (net of allowance for credit losses of $8.6 and $9.8, respectively)", "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r29", "r148", "r712", "r714", "r783" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Accounts Receivable, Related Parties", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r13", "r54", "r536" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual For Taxes Other Than Income Taxes Current", "terseLabel": "Accrued taxes other than income" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r21", "r755", "r777" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes Current", "negatedLabel": "Income taxes payable", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r54" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r760", "r786" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities", "terseLabel": "Accrued liabilities", "totalLabel": "Accrued Liabilities, Total" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r79", "r85", "r93", "r94", "r95", "r613" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment [Member]", "terseLabel": "Pension and Other Postemployment Benefits" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r46", "r268" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedLabel": "Less: Accumulated depreciation", "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance", "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance", "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r85", "r93", "r94", "r95", "r96", "r612" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain Loss Net Cash Flow Hedge Parent [Member]", "terseLabel": "Derivatives" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income Loss [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r33", "r82", "r84", "r85", "r780", "r803", "r804" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r93", "r94", "r671", "r672", "r673", "r674", "r675", "r677" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income Loss [Table]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r81", "r85", "r93", "r94", "r95", "r153", "r154", "r155", "r613", "r799", "r800", "r867" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r77", "r85", "r93", "r94", "r95", "r613", "r672", "r673", "r674", "r675", "r677" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Translation Adjustment [Member]", "terseLabel": "Unrealized Foreign Currency Translation Adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r31", "r530", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid In Capital", "periodEndLabel": "Additional Paid in Capital, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Beginning Balance", "terseLabel": "Additional paid-in capital", "totalLabel": "Additional Paid in Capital, Total" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r153", "r154", "r155", "r527", "r528", "r529", "r654" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r496", "r498", "r533", "r534" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Recognition of stock-based compensation", "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r537" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs Policy [Text Block]", "terseLabel": "Advertising" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r498", "r523", "r532" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Total stock-based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r37", "r236", "r243" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance For Doubtful Accounts Receivable Current", "terseLabel": "Allowance for credit losses" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r109", "r129", "r339", "r681" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails": { "order": 2.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount Premium", "terseLabel": "Original issue discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r104", "r129", "r339", "r683" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails": { "order": 1.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization Of Financing Costs", "terseLabel": "Deferred financing costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r129", "r339", "r350", "r351", "r683" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization Of Financing Costs And Discounts", "terseLabel": "Amortization of deferred financing costs and original issue discount", "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortization Of Financing Costs And Discounts [Abstract]", "terseLabel": "Amortization of:" } } }, "localname": "AmortizationOfFinancingCostsAndDiscountsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r129", "r254", "r261" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization Of Intangible Assets", "terseLabel": "Amortization of intangible assets", "totalLabel": "Amortization of Intangible Assets, Total" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r479" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized in net periodic benefit cost (credit) and other comprehensive (income) loss.", "label": "Amount Recognized In Net Periodic Benefit Cost And Other Comprehensive Income Loss Before Tax", "terseLabel": "Net amount recognized", "totalLabel": "Total recognized in net periodic benefit cost and other comprehensive loss" } } }, "localname": "AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsSummaryOfPretaxAmountsOfNetPeriodicBenefitCostDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": { "auth_ref": [ "r82" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax", "terseLabel": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax" } } }, "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r143", "r208", "r215", "r222", "r241", "r301", "r302", "r303", "r305", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r608", "r614", "r665", "r718", "r720", "r753", "r776" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r8", "r9", "r71", "r143", "r241", "r301", "r302", "r303", "r305", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r608", "r614", "r665", "r718", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r499", "r525" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r627", "r631" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building And Building Improvements [Member]", "terseLabel": "Building and Building Improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r484", "r490" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r484", "r490", "r591", "r592" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition Share Price", "terseLabel": "Share Price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r590" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 8.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Quidel acquisition-related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r596", "r597", "r598" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination Consideration Transferred1", "terseLabel": "Total Consideration", "totalLabel": "Business Combination, Consideration Transferred, Total" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationIntegrationRelatedCosts": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails": { "order": 0.0, "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.", "label": "Business Combination, Integration Related Costs", "terseLabel": "Quidel acquisition-related costs" } } }, "localname": "BusinessCombinationIntegrationRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r4", "r152", "r194" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description And Basis Of Presentation [Text Block]", "terseLabel": "Basis of presentation of the consolidated financial statements" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBasisOfPresentationOfConsolidatedFinancialStatements" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r112" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash Acquired From Acquisition", "terseLabel": "Cash Acquired from Acquisition" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r5", "r42", "r131" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r16", "r134" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash And Cash Equivalents Policy [Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r124", "r131", "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year", "terseLabel": "Cash, cash equivalents and restricted cash", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r124", "r670" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash Equivalents", "totalLabel": "Cash Equivalents, at Carrying Value, Total" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r623" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging", "verboseLabel": "Cash Flow Hedge" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r141", "r143", "r166", "r167", "r168", "r170", "r172", "r180", "r181", "r182", "r241", "r301", "r306", "r307", "r308", "r314", "r315", "r356", "r357", "r360", "r361", "r665", "r837" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class Of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "auth_ref": [ "r601", "r602", "r604" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.", "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "Collaborations and other relationships" } } }, "localname": "CollaborativeArrangementDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationships" ], "xbrltype": "textBlockItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]", "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r60", "r294", "r762", "r785" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies (Note 21)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r291", "r292", "r293", "r296", "r812" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance", "terseLabel": "Shares reserved for future" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r153", "r154", "r654" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Ordinary Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Ordinary shares, value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Ordinary shares, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Ordinary shares, shares issued", "totalLabel": "Common Stock, Shares, Issued, Total" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r28", "r363" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Ordinary shares, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r28", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "terseLabel": "Ordinary shares, $0.00001 par value, 1,000,000,000 shares authorized, 237,203,879 and 147,295,511 shares issued and outstanding as of January 2, 2022 and January 3, 2021, respectively", "totalLabel": "Common Stock, Value, Issued, Total", "verboseLabel": "common stock, value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r405", "r408", "r495", "r535" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation And Employee Benefit Plans [Text Block]", "terseLabel": "Long-Term Employee Benefits" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefits4" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation And Retirement Disclosure [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r88", "r90", "r91", "r102", "r766", "r790" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r101", "r111", "r765", "r789" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income Policy Policy [Text Block]", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r189", "r190", "r232", "r663", "r664", "r811" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r189", "r190", "r232", "r663", "r664", "r805", "r811" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r189", "r190", "r232", "r663", "r664", "r805", "r811" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r189", "r190", "r232", "r663", "r664" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r189", "r190", "r232", "r663", "r664", "r811" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": { "auth_ref": [ "r1", "r151", "r606" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.", "label": "Condensed Financial Information Of Parent Company Only Disclosure [Text Block]", "terseLabel": "Financial Information of Registrant (Parent Company Only)" } } }, "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnly" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction In Progress [Member]", "terseLabel": "Construction in Progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract With Customer Asset And Liability Table [Text Block]", "terseLabel": "Schedule of Balance of Contract Assets Recorded in Consolidated Balance Sheets" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetCreditLossExpense": { "auth_ref": [ "r244", "r374", "r392" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract With Customer Asset Credit Loss Expense", "terseLabel": "Credit losses related to contract assets" } } }, "localname": "ContractWithCustomerAssetCreditLossExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r371", "r373", "r394" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract With Customer Asset Net", "terseLabel": "Contract asset", "totalLabel": "Contract with Customer, Asset, after Allowance for Credit Loss, Total", "verboseLabel": "Total contract assets" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r371", "r372", "r394" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract With Customer Liability Current", "terseLabel": "Deferred revenue, current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r371", "r372", "r394" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract With Customer Liability Noncurrent", "terseLabel": "Deferred revenue, non-current" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r395" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract With Customer Liability Revenue Recognized", "terseLabel": "Deferred revenue, revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r26", "r27", "r362", "r364", "r365" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Preferred redeemable Shares" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r213", "r214", "r215", "r216", "r218", "r224", "r226" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate Non Segment [Member]", "terseLabel": "Corporate, Non-Segment" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r106", "r143", "r241", "r301", "r302", "r303", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r665" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost Of Revenue", "terseLabel": "Cost of Revenue", "totalLabel": "Cost of Revenue, Total", "verboseLabel": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CrossCurrencyInterestRateContractMember": { "auth_ref": [ "r436", "r641" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.", "label": "Cross Currency Interest Rate Contract [Member]", "terseLabel": "Cross Currency Interest Rate Contract" } } }, "localname": "CrossCurrencyInterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred stock upon which unpaid dividends accumulate until paid to shareholders. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Cumulative Preferred Stock [Member]", "terseLabel": "Cumulative Preferred Stock" } } }, "localname": "CumulativePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Federal State And Local Tax Expense Benefit [Abstract]", "terseLabel": "Current" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r144", "r569", "r577" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails": { "order": 0.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense Benefit", "terseLabel": "U.S." } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r144", "r569" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense Benefit", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r144", "r569", "r577", "r579" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails": { "order": 0.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense Benefit", "totalLabel": "Total Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r188", "r232" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r759", "r787" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureBorrowingsComponentsOfBorrowingsDetails2": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt And Capital Lease Obligations", "totalLabel": "Total borrowings" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureBorrowingsComponentsOfBorrowingsDetails2": { "order": 0.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt Current", "negatedLabel": "Less: Current portion", "terseLabel": "Current portion of borrowings", "totalLabel": "Debt, Current, Total", "verboseLabel": "Less: Current portion" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r140", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r333", "r340", "r341", "r343", "r354" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Borrowings" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r20", "r21", "r22", "r142", "r151", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r329", "r330", "r331", "r332", "r334", "r335", "r336", "r337", "r338", "r339", "r348", "r349", "r350", "r351", "r684", "r754", "r757", "r774" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument Basis Spread On Variable Rate1", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r22", "r344", "r757", "r774" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails": { "order": 0.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debt Instrument Carrying Amount", "terseLabel": "Long-term borrowings, outstanding balance", "verboseLabel": "Senior Secured Credit Facilities" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentCovenantDescription": { "auth_ref": [ "r22", "r770" ], "lang": { "en-us": { "role": { "documentation": "Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.", "label": "Debt Instrument Covenant Description", "terseLabel": "Debt instrument, covenant description" } } }, "localname": "DebtInstrumentCovenantDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r316", "r348", "r349", "r682", "r684", "r685" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r56", "r346", "r682", "r684" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "terseLabel": "Debt instrument, effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r56", "r317" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "terseLabel": "Debt instrument, stated interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r57", "r319", "r659" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument Maturity Date", "terseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument Maturity Date Description", "terseLabel": "Debt instrument, maturity date, description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r58", "r142", "r151", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r329", "r330", "r331", "r332", "r334", "r335", "r336", "r337", "r338", "r339", "r348", "r349", "r350", "r351", "r684" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument Redemption Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Five [Member]", "terseLabel": "2025 and Thereafter" } } }, "localname": "DebtInstrumentRedemptionPeriodFiveMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFourMember": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Four [Member]", "terseLabel": "2024" } } }, "localname": "DebtInstrumentRedemptionPeriodFourMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period One [Member]", "terseLabel": "2022" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodStartDate": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Start date of debt instrument redemption period, in YYYY-MM-DD format.", "label": "Debt Instrument Redemption Period Start Date", "terseLabel": "Debt instrument, redemption period start date" } } }, "localname": "DebtInstrumentRedemptionPeriodStartDate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Three [Member]", "terseLabel": "2024 and thereafter" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Two [Member]", "terseLabel": "2023" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r771" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument Redemption Price Percentage", "terseLabel": "Redemption price percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentRedemptionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption.", "label": "Debt Instrument Redemption Table [Text Block]", "terseLabel": "Schedule of Redemption Prices Expressed as Percentages of Principal Amount" } } }, "localname": "DebtInstrumentRedemptionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r58", "r142", "r151", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r329", "r330", "r331", "r332", "r334", "r335", "r336", "r337", "r338", "r339", "r342", "r348", "r349", "r350", "r351", "r364", "r366", "r367", "r368", "r681", "r682", "r684", "r685", "r772" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r329", "r681", "r685" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails": { "order": 6.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument Unamortized Discount", "negatedLabel": "Unamortized original issue discount", "totalLabel": "Debt Instrument, Unamortized Discount, Total" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r144", "r570", "r577" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense Benefit", "terseLabel": "U.S." } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal State And Local Tax Expense Benefit", "totalLabel": "Total Deferred" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Federal State And Local Tax Expense Benefit [Abstract]", "terseLabel": "Deferred" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r683" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Gross", "terseLabel": "Deferred financing costs, gross" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r47", "r329", "r683" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails": { "order": 5.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Net", "negatedLabel": "Unamortized deferred financing costs", "terseLabel": "Unamortized deferred financing costs", "totalLabel": "Debt Issuance Costs, Net, Total", "verboseLabel": "Deferred financing costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r144", "r570", "r577" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense Benefit", "terseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r543", "r544" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets Net", "terseLabel": "Deferred income taxes", "totalLabel": "Deferred Income Tax Assets, Net, Total" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r129", "r144", "r570", "r577", "r578", "r579" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense Benefit", "terseLabel": "Deferred tax benefit", "totalLabel": "Deferred Income Tax Expense (Benefit), Total" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r24", "r25", "r559", "r756", "r773" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Income Tax Liabilities", "negatedTotalLabel": "Total deferred tax liabilities", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r543", "r544" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "negatedLabel": "Deferred income taxes", "terseLabel": "Deferred income taxes", "totalLabel": "Deferred Income Tax Liabilities, Net, Total" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueArrangementTypeAxis": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred revenue arrangement.", "label": "Deferred Revenue Arrangement Type [Axis]" } } }, "localname": "DeferredRevenueArrangementTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueArrangementTypeDomain": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Category of obligation arising when an entity receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized.", "label": "Deferred Revenue [Domain]" } } }, "localname": "DeferredRevenueArrangementTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue Current", "terseLabel": "Deferred revenue", "totalLabel": "Deferred Revenue, Current, Total" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r567" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Deferred Tax Asset Interest Carryforward", "terseLabel": "Deferred Tax Asset, Interest Carryforward" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r560" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Gross", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossNoncurrent": { "auth_ref": [ "r543", "r544", "r560" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as noncurrent.", "label": "Deferred Tax Assets Gross Noncurrent", "terseLabel": "Non-current deferred tax asset" } } }, "localname": "DeferredTaxAssetsGrossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r562" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "totalLabel": "Net, Deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Net [Abstract]", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r567", "r568" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards", "terseLabel": "Tax loss and credit carry forwards", "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total", "verboseLabel": "Net deferred tax asset for tax losses and credit carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration", "terseLabel": "Operating loss carryforwards net, not subject to expiry" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r567", "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards State And Local", "terseLabel": "State operating loss carryforwards net" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r567", "r568" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r565", "r567", "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets Tax Credit Carryforwards", "terseLabel": "Deferred Tax Assets, Tax Credit Carryforwards", "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpense": { "auth_ref": [ "r567", "r568" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowances, of deferred tax asset attributable to deductible differences from reserves and accruals, compensation and benefit costs, and other provisions, reserves, and allowances.", "label": "Deferred Tax Assets Tax Deferred Expense", "terseLabel": "Deferred Tax Assets, Tax Deferred Expense", "totalLabel": "Deferred Tax Assets, Tax Deferred Expense, Total" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r567", "r568" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost", "terseLabel": "Employee related obligations" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r567", "r568" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [ "r567", "r568" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts", "terseLabel": "Allowances and reserves" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r561" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets Valuation Allowance", "negatedLabel": "Less: Valuation Allowance", "periodEndLabel": "Valuation allowance, ending balance", "periodStartLabel": "Valuation allowance, beginning balance", "terseLabel": "Valuation allowance", "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfChangesToTheValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r544", "r562" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "terseLabel": "Net, Deferred tax liability", "totalLabel": "Net, Deferred tax liability" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": { "auth_ref": [ "r567", "r568", "r599", "r600" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.", "label": "Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill", "terseLabel": "Goodwill and intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGrossNoncurrent": { "auth_ref": [ "r543", "r562" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross amount of noncurrent deferred tax liabilities, which result from applying the applicable tax rate to taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax.", "label": "Deferred Tax Liabilities Gross Noncurrent", "terseLabel": "Non-current deferred tax liability" } } }, "localname": "DeferredTaxLiabilitiesGrossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities Net [Abstract]", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r567", "r568" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities Other", "negatedLabel": "Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": { "auth_ref": [ "r443" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.", "label": "Defined Benefit Plan Accumulated Benefit Obligation", "terseLabel": "ABO" } } }, "localname": "DefinedBenefitPlanAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": { "auth_ref": [ "r85", "r455" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.", "label": "Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax", "terseLabel": "Accumulated net actuarial losses" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsSummaryOfPretaxAmountsOfNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": { "auth_ref": [ "r85", "r455" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).", "label": "Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax", "terseLabel": "Accumulated prior service cost" } } }, "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsSummaryOfPretaxAmountsOfNetPeriodicBenefitCostDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": { "auth_ref": [ "r425", "r479" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.", "label": "Defined Benefit Plan Actual Return On Plan Assets", "terseLabel": "Actual return on plan assets" } } }, "localname": "DefinedBenefitPlanActualReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanActuarialGainLoss": { "auth_ref": [ "r418" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.", "label": "Defined Benefit Plan Actuarial Gain Loss", "terseLabel": "Actuarial (gain) loss", "verboseLabel": "Actuarial loss (gain)" } } }, "localname": "DefinedBenefitPlanActuarialGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsSummaryOfPretaxAmountsOfNetPeriodicBenefitCostDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "auth_ref": [ "r411", "r450", "r473", "r479", "r480" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 3.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.", "label": "Defined Benefit Plan Amortization Of Gains Losses", "negatedLabel": "Amortization of net loss", "terseLabel": "Amortization of net loss" } } }, "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r411", "r451", "r474", "r479", "r480" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan Amortization Of Prior Service Cost Credit", "terseLabel": "Amortization of prior service cost" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": { "auth_ref": [ "r409", "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.", "label": "Defined Benefit Plan Amounts Recognized In Balance Sheet", "terseLabel": "Net amount recognized", "totalLabel": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position, Total" } } }, "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate", "terseLabel": "Discount rate to determine benefit obligations" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase", "terseLabel": "Rate of compensation increases to determine benefit obligations" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate", "terseLabel": "Discount rate to determine net cost" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": { "auth_ref": [ "r458", "r478" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.", "label": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets", "terseLabel": "Return on plan assets to determine cost" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.", "label": "Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase", "terseLabel": "Rate of compensation increases to determine net costs" } } }, "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligation": { "auth_ref": [ "r413" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan Benefit Obligation", "periodEndLabel": "Projected benefit obligation at end of year", "periodStartLabel": "Projected benefit obligation at beginning of year" } } }, "localname": "DefinedBenefitPlanBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": { "auth_ref": [ "r420", "r481" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan Benefit Obligation Benefits Paid", "negatedLabel": "Benefits paid", "terseLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": { "auth_ref": [ "r417" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.", "label": "Defined Benefit Plan Benefit Obligation Contributions By Plan Participant", "terseLabel": "Contributions by plan participants" } } }, "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": { "auth_ref": [ "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r461", "r479" ], "lang": { "en-us": { "role": { "documentation": "Information by defined benefit plan asset investment.", "label": "Defined Benefit Plan By Plan Asset Categories [Axis]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category" } } }, "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan Cash And Cash Equivalents [Member]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan Change In Benefit Obligation Roll Forward", "terseLabel": "Change in benefit obligation:" } } }, "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Defined Benefit Plan Change In Fair Value Of Plan Assets Roll Forward", "terseLabel": "Change in plan assets:" } } }, "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "auth_ref": [ "r427", "r436", "r437", "r477", "r479", "r480" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.", "label": "Defined Benefit Plan Contributions By Employer", "terseLabel": "Employer contributions" } } }, "localname": "DefinedBenefitPlanContributionsByEmployer", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDebtSecurityMember": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested.", "label": "Defined Benefit Plan Debt Security [Member]", "terseLabel": "Debt Securities" } } }, "localname": "DefinedBenefitPlanDebtSecurityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanDescriptionOfDirectionAndPatternOfChangeForAssumedHealthCareCostTrendRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of direction and pattern of change in assumed health care cost trend rate used to measure expected cost of benefits for defined benefit postretirement plan.", "label": "Defined Benefit Plan Description Of Direction And Pattern Of Change For Assumed Health Care Cost Trend Rate", "terseLabel": "Trending rate, description" } } }, "localname": "DefinedBenefitPlanDescriptionOfDirectionAndPatternOfChangeForAssumedHealthCareCostTrendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": { "auth_ref": [ "r436", "r479" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan Equity Securities [Member]", "terseLabel": "Equity Securities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": { "auth_ref": [ "r436", "r437", "r479" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan Equity Securities Non Us [Member]", "terseLabel": "Other international equity securities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": { "auth_ref": [ "r436", "r437", "r479" ], "lang": { "en-us": { "role": { "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.", "label": "Defined Benefit Plan Equity Securities Us [Member]", "terseLabel": "US equity securities" } } }, "localname": "DefinedBenefitPlanEquitySecuritiesUsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter", "terseLabel": "Fiscal Year 2027-2031" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.", "label": "Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months", "terseLabel": "Fiscal Year 2022" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.", "label": "Defined Benefit Plan Expected Future Benefit Payments Year Five", "terseLabel": "Fiscal Year 2026" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.", "label": "Defined Benefit Plan Expected Future Benefit Payments Year Four", "terseLabel": "Fiscal Year 2025" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.", "label": "Defined Benefit Plan Expected Future Benefit Payments Year Three", "terseLabel": "Fiscal Year 2024" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": { "auth_ref": [ "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.", "label": "Defined Benefit Plan Expected Future Benefit Payments Year Two", "terseLabel": "Fiscal Year 2023" } } }, "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfExpectedBenefitPaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r411", "r449", "r472", "r479", "r480" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 2.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan Expected Return On Plan Assets", "negatedLabel": "Expected return on plan assets", "terseLabel": "Expected return on plan assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": { "auth_ref": [ "r424", "r436", "r437", "r438", "r479" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.", "label": "Defined Benefit Plan Fair Value Of Plan Assets", "periodEndLabel": "Fair value of plan assets at end of year", "periodStartLabel": "Fair value of plan assets at beginning of year", "totalLabel": "Defined Benefit Plan, Plan Assets, Amount, Total" } } }, "localname": "DefinedBenefitPlanFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": { "auth_ref": [ "r419" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.", "label": "Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation", "terseLabel": "Foreign currency exchange rate changes" } } }, "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "auth_ref": [ "r409", "r433", "r479" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.", "label": "Defined Benefit Plan Funded Status Of Plan", "periodEndLabel": "Funded status at end of year", "terseLabel": "US equity securities", "totalLabel": "Defined Benefit Plan, Funded (Unfunded) Status of Plan, Total" } } }, "localname": "DefinedBenefitPlanFundedStatusOfPlan", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.", "label": "Defined Benefit Plan Health Care Cost Trend Rate Assumed Next Fiscal Year", "terseLabel": "Trending rate, future" } } }, "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r411", "r416", "r448", "r471", "r479", "r480" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 1.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan Interest Cost", "terseLabel": "Interest cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r446", "r469", "r479", "r480" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 1.0, "parentTag": "us-gaap_AmountRecognizedInNetPeriodicBenefitCostAndOtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan Net Periodic Benefit Cost", "terseLabel": "Defined benefit plan, net periodic benefit cost", "totalLabel": "Net periodic benefit cost" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsPretaxAmountsOfNetPeriodicBenefitCostAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Net Periodic Benefit Cost [Abstract]", "terseLabel": "Net periodic benefit cost:" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsAccumulatedBenefitObligation": { "auth_ref": [ "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Accumulated Benefit Obligation", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": { "auth_ref": [ "r465", "r479" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan Pension Plan With Projected Benefit Obligation In Excess Of Plan Assets Projected Benefit Obligation", "terseLabel": "PBO", "verboseLabel": "PBO Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets [Abstract]", "terseLabel": "Plans with ABO in excess of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": { "auth_ref": [ "r465", "r466", "r479" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Accumulated Benefit Obligation", "terseLabel": "ABO" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": { "auth_ref": [ "r465", "r466", "r479" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets", "terseLabel": "Fair value of plan assets" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation": { "auth_ref": [ "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of projected benefit obligation for defined benefit pension plan with accumulated benefit obligation in excess of plan assets.", "label": "Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Projected Benefit Obligation", "terseLabel": "PBO" } } }, "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateProjectedBenefitObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": { "auth_ref": [ "r429", "r481" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.", "label": "Defined Benefit Plan Plan Assets Benefits Paid", "negatedLabel": "Benefits paid", "terseLabel": "Benefits paid" } } }, "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock": { "auth_ref": [ "r436", "r437" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.", "label": "Defined Benefit Plan Plan Assets Category Table [Text Block]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category" } } }, "localname": "DefinedBenefitPlanPlanAssetsCategoryTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": { "auth_ref": [ "r428" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.", "label": "Defined Benefit Plan Plan Assets Contributions By Plan Participant", "terseLabel": "Contributions by plan participants" } } }, "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r426" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.", "label": "Defined Benefit Plan Plan Assets Foreign Currency Translation Gain Loss", "terseLabel": "Foreign currency exchange rate changes" } } }, "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan, Plan Assets, Level 3 Reconciliation [Line Items]" } } }, "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsLevel3ReconciliationTable": { "auth_ref": [ "r438", "r439", "r440", "r441", "r479" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about defined benefit plan assets measured using unobservable inputs.", "label": "Defined Benefit Plan, Plan Assets, Level 3 Reconciliation [Table]" } } }, "localname": "DefinedBenefitPlanPlanAssetsLevel3ReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": { "auth_ref": [ "r435", "r479" ], "lang": { "en-us": { "role": { "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.", "label": "Defined Benefit Plan Plan Assets Target Allocation Percentage", "terseLabel": "Allocation targets" } } }, "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Plans With Benefit Obligations In Excess Of Plan Assets [Abstract]", "terseLabel": "Plans with PBO in excess of plan assets" } } }, "localname": "DefinedBenefitPlanPlansWithBenefitObligationsInExcessOfPlanAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfDefinedBenefitObligationInExcessOfPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": { "auth_ref": [ "r412", "r453", "r476" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.", "label": "Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments", "terseLabel": "Curtailment" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "auth_ref": [ "r412", "r453", "r476" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 4.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.", "label": "Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1", "negatedLabel": "Settlement loss (gain)", "terseLabel": "Settlement loss (gain)" } } }, "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanRollForwardsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Roll Forwards [Abstract]", "terseLabel": "Defined Benefit Plans" } } }, "localname": "DefinedBenefitPlanRollForwardsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanServiceCost": { "auth_ref": [ "r414", "r447", "r470", "r479", "r480" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails": { "order": 0.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.", "label": "Defined Benefit Plan Service Cost", "terseLabel": "Service cost" } } }, "localname": "DefinedBenefitPlanServiceCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": { "auth_ref": [ "r432" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.", "label": "Defined Benefit Plan Settlements Plan Assets", "negatedLabel": "Settlements", "terseLabel": "Settlements" } } }, "localname": "DefinedBenefitPlanSettlementsPlanAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.", "label": "Defined Benefit Plan Ultimate Health Care Cost Trend Rate1", "terseLabel": "Trending rate" } } }, "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Defined Benefit Plan Weighted Average Assumptions Used In Calculating Benefit Obligation [Abstract]", "terseLabel": "Defined Benefit Plans" } } }, "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsScheduleOfDefinedBenefitPlansDisclosuresDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Year ultimate health care cost trend rate is expected to be reached, in YYYY format.", "label": "Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate", "terseLabel": "Trend rate, year" } } }, "localname": "DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "gYearListItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Discretionary Contribution Amount", "terseLabel": "Defined contribution plan to employees" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r129", "r266" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation Expense", "totalLabel": "Depreciation, Total" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r129", "r266" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 14.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation And Amortization", "negatedLabel": "Depreciation and amortization", "terseLabel": "Depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNotionalAmount": { "auth_ref": [ "r619", "r620", "r622" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative asset.", "label": "Derivative Asset Notional Amount", "terseLabel": "Debt instrument notional amount" } } }, "localname": "DerivativeAssetNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAverageFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average fixed interest rate related to the group of interest rate derivatives.", "label": "Derivative Average Fixed Interest Rate", "terseLabel": "Derivative Average Fixed Interest Rate" } } }, "localname": "DerivativeAverageFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeCapInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cap rate on an interest rate derivative such as an interest rate cap or collar. If market rates exceed the cap rate, a payment or receipt is triggered on the contract.", "label": "Derivative Cap Interest Rate", "terseLabel": "Interest rate cap amount" } } }, "localname": "DerivativeCapInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]", "terseLabel": "Derivative Contract" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r75", "r628", "r630", "r637", "r643" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]", "terseLabel": "Derivative Instrument" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments And Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r653", "r656" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments And Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivities1" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r625", "r628", "r637" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Derivative Instruments Gain Loss By Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r625", "r628", "r637", "r643", "r644", "r648", "r650" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "auth_ref": [ "r652" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.", "label": "Derivative Instruments Gain Loss Reclassification From Accumulated O C I To Income Estimated Net Amount To Be Transferred", "terseLabel": "Amount reclassified from AOCI into income due to a forecast transaction that is no longer probable of occurring" } } }, "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r634", "r642" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments Gain Loss Reclassified From Accumulated O C I Into Income Effective Portion Net", "negatedLabel": "Amount of loss (gain) reclassified from AOCI into income", "terseLabel": "Amount of loss (gain) reclassified from AOCI into income", "totalLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total", "verboseLabel": "Amount of loss (gain) reclassified from accumulated OCI into income" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r72" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liabilities Current", "terseLabel": "Derivatives" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r620", "r622" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative Notional Amount", "terseLabel": "Notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative Remaining Maturity1", "terseLabel": "Derivative Remaining Maturity1" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r618", "r621", "r622", "r625", "r626", "r632", "r637", "r646", "r647", "r650", "r653" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesMethodsOfAccountingHedgingDerivatives": { "auth_ref": [ "r645" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for derivatives used in hedging relationships, which may include how gains or losses are recognized and presented in the financial statements, and amortization policies for deferred amounts.", "label": "Derivatives Methods Of Accounting Hedging Derivatives", "terseLabel": "Derivatives and Hedging" } } }, "localname": "DerivativesMethodsOfAccountingHedgingDerivatives", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated As Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation Of Revenue [Line Items]", "terseLabel": "Disaggregation Of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r393", "r397", "r398", "r399", "r400", "r401", "r402", "r403" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table]", "terseLabel": "Disaggregation Of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue Table [Text Block]", "terseLabel": "Summary of Net Revenue by Line of Business" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r535" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Stock-based compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensation1" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]", "terseLabel": "Domestic Tax Authority" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r49", "r148", "r304", "r306", "r307", "r313", "r314", "r315", "r712" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due To Related Parties Current", "terseLabel": "Due to related party", "totalLabel": "Due to Related Parties, Current, Total" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "E M E A [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EarliestTaxYearMember": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Earliest identified tax year.", "label": "Earliest Tax Year [Member]", "terseLabel": "Beginning Year" } } }, "localname": "EarliestTaxYearMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarlyRepaymentOfSeniorDebt": { "auth_ref": [ "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.", "label": "Early Repayment Of Senior Debt", "terseLabel": "Early repayment of debt" } } }, "localname": "EarlyRepaymentOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "terseLabel": "Basic and diluted net loss per ordinary share", "totalLabel": "Earnings Per Share, Basic and Diluted, Total", "verboseLabel": "Basic and diluted net income (loss) per ordinary share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share Policy [Text Block]", "terseLabel": "Net Loss per Ordinary Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r670" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "terseLabel": "Effect of exchange rate changes on cash", "totalLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r546" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Continuing Operations", "negatedTotalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total", "terseLabel": "Effective tax rate", "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r146", "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 0.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate", "terseLabel": "Corporate Tax Rate Decrease", "verboseLabel": "U.S. Statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance", "negatedLabel": "Change in valuation allowance", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate", "terseLabel": "Foreign tax rate change" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential", "terseLabel": "Comparision of statutory rate to effective tax rate", "verboseLabel": "Foreign income taxed at rates other than the applicable U.S. rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 10.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.", "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense", "negatedLabel": "Nondeductible/nontaxable items", "terseLabel": "Nondeductible/nontaxable items", "totalLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent, Total" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 12.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent", "negatedLabel": "Stock-based compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation Other Adjustments", "terseLabel": "Change in uncertain tax positions" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 13.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation Other Reconciling Items Percent", "terseLabel": "Other\u2014net", "totalLabel": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent, Total" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation State And Local Income Taxes", "negatedLabel": "U.S. state and local", "terseLabel": "U.S. state and local" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": { "auth_ref": [ "r546", "r581" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation Tax Credits", "terseLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent", "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total", "verboseLabel": "Tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionToTheUsStatutoryRateDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r54" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 0.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Accrued compensation and employee-related obligations", "totalLabel": "Employee-related Liabilities, Current, Total" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r524" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized", "terseLabel": "Unrecognized Share-Based Compensation Expense", "totalLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r524" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Unrecognized compensation expense, weighted average period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r524" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized compensation expense, outstanding unvested stock options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r93", "r94", "r95", "r153", "r154", "r155", "r157", "r162", "r164", "r179", "r242", "r363", "r369", "r527", "r528", "r529", "r573", "r574", "r654", "r671", "r672", "r673", "r674", "r675", "r677", "r799", "r800", "r801", "r867" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r239" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Investment common shares, percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsPolicy": { "auth_ref": [ "r43", "r123", "r240", "r665" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.", "label": "Equity Method Investments Policy", "terseLabel": "Equity Investments" } } }, "localname": "EquityMethodInvestmentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]", "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r657", "r661", "r662" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value By Balance Sheet Grouping [Table]", "terseLabel": "Fair Value By Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r657", "r661" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value By Balance Sheet Grouping [Text Block]", "terseLabel": "Schedule of Fair Value of Long-term Borrowings" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r331", "r348", "r349", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r479", "r658", "r722", "r723", "r724" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Accounting" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFairValueAccounting1" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r331", "r436", "r437", "r442", "r479", "r658", "r722" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r331", "r348", "r349", "r436", "r437", "r442", "r479", "r658", "r723" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r331", "r348", "r349", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r479", "r658", "r724" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement Policy Policy [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r331", "r348", "r349", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r479", "r722", "r723", "r724" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsScheduleOfAllocationOfPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails": { "order": 1.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "terseLabel": "Finance lease obligation", "totalLabel": "Finance Lease, Liability, Payment, Due, Total" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite Lived Intangible Asset Useful Life", "terseLabel": "Estimated useful lives" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r260" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "negatedLabel": "Accumulated amortization", "terseLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the next rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfAmortizationExpensesOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fifth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite Lived Intangible Assets Amortization Expense Rolling Year Five", "terseLabel": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfAmortizationExpensesOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the fourth rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite Lived Intangible Assets Amortization Expense Rolling Year Four", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfAmortizationExpensesOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the third rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite Lived Intangible Assets Amortization Expense Rolling Year Three", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfAmortizationExpensesOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the second rolling twelve months following the latest balance sheet. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite Lived Intangible Assets Amortization Expense Rolling Year Two", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfAmortizationExpensesOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite Lived Intangible Assets Amortization Expense Table [Text Block]", "terseLabel": "Summary of Estimated Assets Amortization Expense of Acquired Intangible Assets" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r255", "r256", "r260", "r262", "r735", "r736" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r260", "r736" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails": { "order": 0.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Gross carrying amount", "totalLabel": "Finite-Lived Intangible Assets, Gross, Total" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived Intangible Assets [Line Items]", "terseLabel": "Finite Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r255", "r259" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r260", "r735" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Net", "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance", "periodStartLabel": "Finite-Lived Intangible Assets, Net, Beginning Balance", "totalLabel": "Net book value" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Country [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": { "auth_ref": [ "r651" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months", "terseLabel": "Pre-tax unrealized gain within OCI to be reclassified to earnings in next 12 months, foreign currency contracts" } } }, "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": { "auth_ref": [ "r630" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.", "label": "Foreign Currency Fair Value Hedge Asset At Fair Value", "terseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue": { "auth_ref": [ "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments.", "label": "Foreign Currency Fair Value Hedge Liability At Fair Value", "terseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignCurrencyFairValueHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r666", "r667", "r668", "r669" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Before Tax", "terseLabel": "Foreign Currency Transaction Gain (Loss), before Tax", "totalLabel": "Foreign Currency Transaction Gain (Loss), before Tax, Total" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r130", "r668", "r669" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Unrealized", "terseLabel": "Foreign Currency Transaction Gain (Loss), Unrealized" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r678" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions And Translations Policy [Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign Exchange Forward", "verboseLabel": "Foreign Currency Derivatives" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets": { "auth_ref": [ "r129", "r265", "r270" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.", "label": "Gain Loss On Disposition Of Assets", "terseLabel": "Loss on disposal of fixed assets" } } }, "localname": "GainLossOnDispositionOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r628", "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.", "label": "Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments", "terseLabel": "Foreign currency derivatives" } } }, "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInterestRateCashFlowHedgeIneffectiveness": { "auth_ref": [ "r635" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net gain (loss) during the reporting period due to ineffectiveness in interest rate cash flow hedges. Recognized in earnings.", "label": "Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness", "terseLabel": "Gain (Loss) on Interest Rate Cash Flow Hedge Ineffectiveness" } } }, "localname": "GainLossOnInterestRateCashFlowHedgeIneffectiveness", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r628", "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) included in earnings for the period from the increase (decrease) in fair value of interest rate derivatives not designated as hedging instruments.", "label": "Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments", "terseLabel": "Interest rate cap derivatives" } } }, "localname": "GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r129", "r352", "r353" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gains Losses On Extinguishment Of Debt", "negatedLabel": "Loss on extinguishment of debt", "terseLabel": "Loss on extinguishment of debt", "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralBusinessMember": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Tax credit carryforwards which include, but are not limited to, investment, alcohol fuels, low income housing, alternative fuels, alternative motor vehicles, hurricane relief, disabled access, renewable resources electricity production, employer social security, orphan drug, new markets, employer provided child care facilities and services, biodiesel fuels, low sulfur diesel fuel production, distilled spirits and the advanced nuclear power facilities credit.", "label": "General Business [Member]", "terseLabel": "General Business Tax Credit Carryforward" } } }, "localname": "GeneralBusinessMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicAreasLongLivedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geographic Areas Long Lived Assets [Abstract]", "terseLabel": "Long-lived assets" } } }, "localname": "GeographicAreasLongLivedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "stringItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r248", "r249", "r720", "r751" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance at end of fiscal year", "periodStartLabel": "Balance at beginning of fiscal year", "terseLabel": "Goodwill", "totalLabel": "Goodwill, Total" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill And Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Other Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r251", "r257" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill And Intangible Assets Policy [Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r250" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Foreign Currency Translation Gain Loss", "negatedLabel": "Foreign currency translation", "terseLabel": "Foreign currency translation" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrantMember": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Award of money not required to be repaid.", "label": "Grant [Member]", "terseLabel": "Grant" } } }, "localname": "GrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r625", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "I P O [Member]", "terseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r264", "r273" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r145", "r580" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeLossFromContinuingOperationsBeforeIncomeTaxesDetails": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income Loss From Continuing Operations Before Income Taxes Domestic", "terseLabel": "U.S." } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeLossFromContinuingOperationsBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r99", "r208", "r214", "r218", "r221", "r224", "r749", "r763", "r768", "r791" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeLossFromContinuingOperationsBeforeIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "terseLabel": "Pre-tax net profit", "totalLabel": "Loss before provision for (benefit from) income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeLossFromContinuingOperationsBeforeIncomeTaxesDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r145", "r580" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeLossFromContinuingOperationsBeforeIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income Loss From Continuing Operations Before Income Taxes Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeLossFromContinuingOperationsBeforeIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r271", "r279" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r146", "r547", "r557", "r564", "r575", "r582", "r587", "r588", "r589" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxes1" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r147", "r163", "r164", "r206", "r545", "r576", "r585", "r792" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "negatedLabel": "Provision for (benefit from) income taxes", "terseLabel": "Provision for (benefit from) income taxes", "totalLabel": "Provision for (benefit from) income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r92", "r541", "r542", "r557", "r558", "r563", "r571" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax Policy [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r540", "r546" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount", "terseLabel": "Net Cost Due to Tax Rate Difference" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r125", "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r128" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase Decrease In Accounts Payable And Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities", "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r128" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase Decrease In Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r128" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase Decrease In Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r128" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories", "totalLabel": "Increase (Decrease) in Inventories, Total" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapital": { "auth_ref": [ "r128" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.", "label": "Increase (Decrease) in Operating Capital", "negatedLabel": "Changes in operating assets and liabilities", "totalLabel": "Increase (Decrease) in Operating Capital, Total", "verboseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r253", "r258" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets Net Excluding Goodwill", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestCostsCapitalized": { "auth_ref": [ "r680" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails": { "order": 5.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest capitalized during the period.", "label": "Interest Costs Capitalized", "negatedLabel": "Less: Capitalized interest", "terseLabel": "Less: Capitalized interest" } } }, "localname": "InterestCostsCapitalized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r97", "r202", "r679", "r683", "r767" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 13.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense, net", "terseLabel": "Interest expense, net", "totalLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r109", "r337", "r347", "r350", "r351" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails": { "order": 0.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense Debt", "terseLabel": "Interest expense", "totalLabel": "Interest Expense, Debt, Total" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r642" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]", "terseLabel": "Interest Expense", "verboseLabel": "Interest Expense, Net" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r135" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Interest Paid", "totalLabel": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r13", "r14", "r54" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "auth_ref": [ "r651" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.", "label": "Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net", "terseLabel": "Pre-tax unrealized loss within OCI to be reclassified to earnings in next 12 months, interest rate derivative instruments" } } }, "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r75", "r436", "r640" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest Rate Contract", "verboseLabel": "Interest Rate Derivatives" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueInStat", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateFairValueHedgeLiabilityAtFairValue": { "auth_ref": [ "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as interest rate fair value hedging instruments.", "label": "Interest Rate Fair Value Hedge Liability At Fair Value", "terseLabel": "Interest rate derivative contracts" } } }, "localname": "InterestRateFairValueHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r640" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r64" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory Finished Goods", "terseLabel": "Finished goods", "totalLabel": "Inventory, Finished Goods, Gross, Total" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r67" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory Gross", "totalLabel": "Total Inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r6", "r67", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventories", "totalLabel": "Inventory, Net, Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r15", "r68", "r138", "r175", "r245", "r246", "r247", "r732" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory Policy [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r66" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 0.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Inventory Raw Materials And Supplies", "terseLabel": "Raw materials and supplies", "totalLabel": "Inventory, Raw Materials and Supplies, Gross, Total" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r65" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory Work In Process", "terseLabel": "Goods in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LatestTaxYearMember": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Latest identified tax year.", "label": "Latest Tax Year [Member]", "terseLabel": "Ending Year" } } }, "localname": "LatestTaxYearMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Rent expense", "totalLabel": "Operating Leases, Rent Expense, Total" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r702", "r704" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "terseLabel": "Lease transactions", "totalLabel": "Lease, Cost, Total" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r702" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r267" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Land and leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOperatingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases, Operating [Abstract]" } } }, "localname": "LeasesOperatingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r696" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseDiscountRate": { "auth_ref": [ "r695" ], "lang": { "en-us": { "role": { "documentation": "Discount rate used by lessee to determine present value of operating lease payments.", "label": "Lessee, Operating Lease, Discount Rate", "terseLabel": "Lease weighted average discount rate" } } }, "localname": "LesseeOperatingLeaseDiscountRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r703" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r703" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails2": { "order": 0.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "terseLabel": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r693" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Remaining Lease Term", "terseLabel": "Remaining lease term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r694" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Renewal Term", "terseLabel": "Option to extend lease term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r694" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Lease term of contract" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r705" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeaseLeaseNotYetCommencedTermOfContract1": { "auth_ref": [ "r707" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Lease Not yet Commenced, Term of Contract", "terseLabel": "Reagent rental agreement term" } } }, "localname": "LessorOperatingLeaseLeaseNotYetCommencedTermOfContract1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters Of Credit Outstanding Amount", "terseLabel": "Letters of Credit Outstanding, Amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r53", "r143", "r216", "r241", "r301", "r302", "r303", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r609", "r614", "r615", "r665", "r718", "r719" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r36", "r143", "r241", "r665", "r720", "r758", "r782" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and shareholders' equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and Shareholders' Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r55", "r143", "r241", "r301", "r302", "r303", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r609", "r614", "r615", "r665", "r718", "r719", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LienCategoryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by category of lien, for example, but not limited to, senior or junior.", "label": "Lien Category [Axis]", "terseLabel": "Lien Category" } } }, "localname": "LienCategoryAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LienCategoryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal claim on the property of another party to secure the payment of a debt or the satisfaction of an obligation by category, for example, but not limited to, senior or junior.", "label": "Lien Category [Domain]", "terseLabel": "Lien Category" } } }, "localname": "LienCategoryDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r22", "r757", "r774" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line Of Credit", "terseLabel": "Long-term Line of Credit", "totalLabel": "Long-term Line of Credit, Total" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r51", "r142" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Line Of Credit Facility [Axis]", "terseLabel": "Lender Name" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r142" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line Of Credit Facility Increase Decrease For Period Net", "terseLabel": "Line of credit, increase in borrowing capacity", "totalLabel": "Line of Credit Facility, Increase (Decrease), Net, Total" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r51", "r142" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line Of Credit Facility Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Line of credit, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line Of Credit Facility Remaining Borrowing Capacity", "terseLabel": "Line of credit, available borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line Of Credit Facility Unused Capacity Commitment Fee Percentage", "terseLabel": "unused revolving credit facility commitment fees" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LoansAndLeasesReceivableGrossCarryingAmount": { "auth_ref": [ "r234" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allowance of loans and leases held in portfolio, including but not limited to, commercial and consumer loans. Includes deferred interest and fees, undisbursed portion of loan balance, unamortized costs and premiums and discounts from face amounts. Excludes loans and leases covered under loss sharing agreements.", "label": "Loans And Leases Receivable Gross Carrying Amount", "terseLabel": "Loans receivable from subsidiaries", "totalLabel": "Loans and Leases Receivable, Gross, Total" } } }, "localname": "LoansAndLeasesReceivableGrossCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate L I B O R [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR)" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r22", "r330", "r345", "r348", "r349", "r757", "r778" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "totalLabel": "Long-term Debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r22" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureBorrowingsComponentsOfBorrowingsDetails2": { "order": 1.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long Term Debt And Capital Lease Obligations", "terseLabel": "Long-term borrowings", "totalLabel": "Long-term borrowings" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long Term Debt Fair Value", "terseLabel": "Long-term borrowings, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFairValueAccountingScheduleOfFairValueOfLongTermBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r151", "r299", "r335" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 5.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r151", "r299", "r335" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 0.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "auth_ref": [ "r151", "r299", "r335" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 4.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long-Term Debt, Maturity, Year Five", "terseLabel": "2026" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r151", "r299", "r335" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r151", "r299", "r335" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r151", "r299", "r335" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r58" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Longterm Debt Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r58", "r300" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery And Equipment [Member]", "terseLabel": "Machinery and Equipment" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManufacturedProductOtherMember": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by labor or machinery, classified as other.", "label": "Manufactured Product Other [Member]", "terseLabel": "Other Product Revenue" } } }, "localname": "ManufacturedProductOtherMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Minority Interest Ownership Percentage By Parent", "verboseLabel": "Ownership interest" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r183", "r194" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature Of Operations", "terseLabel": "General and Description of the Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r124", "r126", "r130" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "negatedTotalLabel": "Cash used in operating activities", "terseLabel": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r3", "r86", "r89", "r95", "r100", "r130", "r143", "r156", "r158", "r159", "r160", "r161", "r163", "r164", "r169", "r208", "r214", "r218", "r221", "r224", "r241", "r301", "r302", "r303", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r655", "r665", "r764", "r788" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": 0.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgeDerivativeLiabilitiesAtFairValue": { "auth_ref": [ "r630" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of all derivative liabilities designated as hedges of net investment in foreign operations.", "label": "Net Investment Hedge Derivative Liabilities At Fair Value", "terseLabel": "Net investment in a foreign operation, designated as economic hedge" } } }, "localname": "NetInvestmentHedgeDerivativeLiabilitiesAtFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r624" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedge" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "New Accounting Guidance" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing And Financing Items [Abstract]" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r229" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Noncurrent Assets", "terseLabel": "Long-lived assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r625" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Nondesignated [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number Of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs And Expenses", "terseLabel": "Joint Business operating expense", "totalLabel": "Total other operating expense, net" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r208", "r214", "r218", "r221", "r224" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "terseLabel": "Total other operating expense, net", "totalLabel": "Income from operations", "verboseLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Income Loss [Abstract]" } } }, "localname": "OperatingIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r697", "r704" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r690" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails2": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Present value of lease liabilities", "totalLabel": "Operating Lease, Liability, Total", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesLesseeOperatingLeaseLiabilityMaturityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease, Liability [Abstract]" } } }, "localname": "OperatingLeaseLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfSupplementalBalanceSheetInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r690" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Current portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r692", "r698" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r691" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r701", "r704" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r700", "r704" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term (years)" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease": { "auth_ref": [ "r266", "r706" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of depreciation expense for lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Depreciation, Lessor Asset under Operating Lease", "terseLabel": "Depreciation expense" } } }, "localname": "OperatingLeasesIncomeStatementDepreciationExpenseOnPropertySubjectToOrHeldForLease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r565" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "U.S. Federal Net Operating Loss Carryforwards", "totalLabel": "Operating Loss Carryforwards, Total" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]", "terseLabel": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]", "terseLabel": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsValuationAllowance": { "auth_ref": [ "r561" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.", "label": "Operating Loss Carryforwards, Valuation Allowance", "terseLabel": "Net Cost Impact Due To Valuation Allowances", "totalLabel": "Operating Loss Carryforwards, Valuation Allowance, Total" } } }, "localname": "OperatingLossCarryforwardsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r213", "r214", "r215", "r216", "r218", "r224" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r11", "r13", "r14", "r54" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r19", "r752", "r775" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "terseLabel": "Other Assets", "totalLabel": "Total Other Assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets [Abstract]" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r69", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAsset" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r627", "r648" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other assets", "totalLabel": "Other Assets, Noncurrent, Total" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r85", "r93", "r94", "r96", "r671", "r673", "r677" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": 0.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Before Reclassifications Net Of Tax", "terseLabel": "Current period deferrals" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r93", "r94", "r101", "r238", "r671", "r676", "r677", "r765", "r789" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": 0.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Before Tax", "totalLabel": "Other comprehensive income (loss), before tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income (loss), before tax:" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r78", "r82" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax", "terseLabel": "Foreign currency derivatives, net of tax of $0.0", "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Total", "verboseLabel": "Interest rate derivatives, net of tax of $0.0" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": { "auth_ref": [ "r78", "r82" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax", "terseLabel": "Derivatives", "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Total", "verboseLabel": "Interest rate derivatives" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r83" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax", "terseLabel": "Derivatives, tax", "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r78", "r82", "r629", "r633", "r649" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax", "negatedLabel": "Amount of loss (gain) recognized in OCI on hedges", "terseLabel": "Amount of loss (gain) recognized in OCI on hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r76", "r82" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": 0.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax", "terseLabel": "Foreign currency translation adjustments", "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax", "terseLabel": "Foreign currency translation adjustments", "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r87", "r90", "r93", "r94", "r96", "r101", "r363", "r671", "r676", "r677", "r765", "r789" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Net change", "negatedTotalLabel": "Net change", "terseLabel": "Equity in other comprehensive income (loss) of subsidiaries", "totalLabel": "Other comprehensive income (loss), net of tax", "verboseLabel": "Net change" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "auth_ref": [ "r80", "r82", "r454", "r479" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "negatedLabel": "Pension and other postemployment benefits", "terseLabel": "Pension and other postemployment benefits", "totalLabel": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r83", "r93", "r101", "r545", "r584", "r586", "r671", "r674", "r677", "r765", "r789" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Tax", "terseLabel": "Income tax benefit related to items of other comprehensive income (loss)", "totalLabel": "Other Comprehensive Income (Loss), Tax, Total" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostAndExpenseOperating": { "auth_ref": [ "r107" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingCostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Cost And Expense Operating", "terseLabel": "Other(1)", "totalLabel": "Other Cost and Expense, Operating, Total" } } }, "localname": "OtherCostAndExpenseOperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r627", "r648" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other (Including Milestone Payments)" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r761" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "terseLabel": "Other liabilities", "totalLabel": "Other Liabilities, Total" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfSupplementalBalanceSheetInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r59" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other liabilities", "totalLabel": "Other Liabilities, Noncurrent, Total" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r22", "r757", "r778" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails": { "order": 4.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long Term Debt", "terseLabel": "Other long-term borrowings", "totalLabel": "Other Long-term Debt, Total" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r130" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income Expense", "negatedLabel": "Other non-cash, net", "totalLabel": "Other Noncash Income (Expense), Total" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other Noncurrent Assets", "verboseLabel": "Other Assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Noncurrent Liabilities", "verboseLabel": "Other Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r110" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "negatedLabel": "Other expense, net", "terseLabel": "Other Nonoperating Income (Expense)", "totalLabel": "Other Nonoperating Income (Expense), Total" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income Expense [Member]", "terseLabel": "Other Expense, Net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfFairValueGainsAndLossesOfDerivativeContractsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherOperatingIncomeAndExpenseTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other operating income and other operating expense items.", "label": "Other Operating Income And Expense [Text Block]", "terseLabel": "Other Financial Information" } } }, "localname": "OtherOperatingIncomeAndExpenseTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureOtherFinancialInformation1" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income Expense Net", "negatedLabel": "Other operating expense, net", "terseLabel": "Other operating expense, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r407", "r409", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r461", "r462", "r464", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r482", "r483", "r484", "r485", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefit Plans Defined Benefit [Member]", "terseLabel": "Other Postemployment Benefits" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestructuringCosts": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.", "label": "Other Restructuring Costs", "terseLabel": "Other costs" } } }, "localname": "OtherRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSellingAndMarketingExpense": { "auth_ref": [ "r108" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of selling and marketing expense classified as other.", "label": "Other Selling and Marketing Expense", "terseLabel": "Selling, marketing and administrative expenses" } } }, "localname": "OtherSellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementOfOperationAndComprehensiveLossDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherShortTermBorrowings": { "auth_ref": [ "r48" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails": { "order": 3.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.", "label": "Other Short Term Borrowings", "terseLabel": "Other short-term borrowings" } } }, "localname": "OtherShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over Allotment Option [Member]", "terseLabel": "Over-Allotment Option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables And Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentForManagementFee": { "auth_ref": [ "r121", "r711" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Payment For Management Fee", "terseLabel": "Management fee" } } }, "localname": "PaymentForManagementFee", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": { "auth_ref": [ "r120" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.", "label": "Payment of Financing and Stock Issuance Costs", "negatedLabel": "Payment of initial public offering costs", "terseLabel": "Payment of initial public offering costs", "totalLabel": "Payment of Financing and Stock Issuance Costs, Total" } } }, "localname": "PaymentOfFinancingAndStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForHedgeInvestingActivities": { "auth_ref": [ "r114", "r127" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.", "label": "Payments For Hedge Investing Activities", "terseLabel": "Payments For Hedge Investing Activities" } } }, "localname": "PaymentsForHedgeInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromLoansReceivable": { "auth_ref": [ "r132", "r133" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services.", "label": "Payments For Proceeds From Loans Receivable", "negatedLabel": "Net increase in intercompany loans", "terseLabel": "Loans to subsidiaries", "totalLabel": "Payments for (Proceeds from) Loans Receivable, Total", "verboseLabel": "Net decrease (increase) in intercompany loans" } } }, "localname": "PaymentsForProceedsFromLoansReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r117" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments For Repurchase Of Common Stock", "negatedLabel": "Repurchase of common stock", "terseLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r121", "r278" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments For Restructuring", "terseLabel": "Payments made" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payments Of Debt Extinguishment Costs", "terseLabel": "Redemption premium" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r120" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "terseLabel": "Costs related to issuance of Term Loan Facilities", "totalLabel": "Payments of Financing Costs, Total" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r113" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchase of property, plant and equipment", "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r23", "r409", "r410", "r433", "r479" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent", "terseLabel": "Employee-related obligations", "totalLabel": "Liability, Defined Benefit Plan, Noncurrent, Total" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance Shares" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanAssetCategoriesDomain": { "auth_ref": [ "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r461", "r479" ], "lang": { "en-us": { "role": { "documentation": "Defined benefit plan asset investment.", "label": "Plan Asset Categories [Domain]", "terseLabel": "Defined Benefit Plan, Plan Assets, Category" } } }, "localname": "PlanAssetCategoriesDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r499", "r525" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PostemploymentBenefitsPeriodExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Period expense related to postemployment benefits.", "label": "Postemployment Benefits Period Expense", "negatedLabel": "Pension and other postemployment benefits, net of tax of $0.0", "terseLabel": "Pension and other postemployment benefits, net of tax of $0.0" } } }, "localname": "PostemploymentBenefitsPeriodExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock Dividend Rate Percentage", "terseLabel": "Preferred Stock, Dividend Rate, Percentage" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Redeemable Shares" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r27", "r356" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, nominal value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionAmount": { "auth_ref": [ "r61", "r355" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.", "label": "Preferred Stock Redemption Amount", "terseLabel": "Preferred Stock, Redemption Amount" } } }, "localname": "PreferredStockRedemptionAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r27", "r356" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Cumulative Redeemable Preferred Stock Shares", "totalLabel": "Preferred Stock, Shares Issued, Total", "verboseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetailsParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r27", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "terseLabel": "Preferred Redeemable shares, $1.39 nominal value per share, 50,000 and no shares issued and outstanding as of January 2, 2022 and January 3, 2021, respectively", "totalLabel": "Preferred Stock, Value, Issued, Total" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r115" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds From Issuance Initial Public Offering", "terseLabel": "Proceeds from Issuance Initial Public Offering", "verboseLabel": "Proceeds from initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r116" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds From Issuance Of Long Term Debt", "terseLabel": "Proceeds from long-term debt", "totalLabel": "Proceeds from Issuance of Long-term Debt, Total" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r115", "r526" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds From Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r3", "r86", "r89", "r95", "r122", "r143", "r156", "r163", "r164", "r208", "r214", "r218", "r221", "r224", "r241", "r301", "r302", "r303", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r607", "r610", "r611", "r616", "r617", "r655", "r665", "r768" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails3": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "terseLabel": "Net loss", "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfCashFlowsDetails", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property Plant And Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r46", "r269" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r274", "r813", "r814", "r815" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property Plant And Equipment Disclosure [Text Block]", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosurePropertyPlantAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r45", "r267" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails": { "order": 0.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Gross", "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance", "terseLabel": "Total property, plant and equipment", "totalLabel": "Total property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property Plant And Equipment [Line Items]", "terseLabel": "Property Plant And Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r17", "r18", "r269", "r720", "r769", "r784" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Net property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r44", "r269", "r813", "r814" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property Plant And Equipment Policy [Text Block]", "terseLabel": "Property, Plant and Equipment and Depreciation" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r17", "r269" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property Plant And Equipment [Text Block]", "terseLabel": "Schedule of Property, Plant and Equipment Recorded at Cost" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r17", "r267" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property Plant And Equipment Useful Life", "terseLabel": "Leasehold improvements" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation": { "auth_ref": [ "r268", "r687", "r688", "r706" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesEquipmentLeasedToCustomersDetails": { "order": 1.0, "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, Accumulated Depreciation", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesEquipmentLeasedToCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseGross": { "auth_ref": [ "r267", "r686", "r688", "r706" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesEquipmentLeasedToCustomersDetails": { "order": 0.0, "parentTag": "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, before Accumulated Depreciation", "terseLabel": "Customer leased instruments" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesEquipmentLeasedToCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet": { "auth_ref": [ "r269", "r688", "r706" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesEquipmentLeasedToCustomersDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation", "totalLabel": "Total Customer leased instruments, net" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesEquipmentLeasedToCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r103", "r244" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision For Doubtful Accounts", "terseLabel": "Change in allowance for credit losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "Unaudited Quarterly Financial Information" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureUnauditedQuarterlyFinancialInformation1" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r85", "r93", "r94", "r96", "r671", "r675", "r677" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax", "negatedLabel": "Amounts reclassified to net loss", "terseLabel": "Amounts reclassified to net loss" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r214", "r218" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation Of Operating Profit Loss From Segments To Consolidated [Text Block]", "terseLabel": "Reconciliation of Net Loss to Adjusted EBITDA" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r461", "r711", "r712" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r461", "r711", "r712", "r714" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r461", "r711", "r714", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r709", "r710", "r712", "r715", "r716" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments Of Debt", "terseLabel": "Repayments of Debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r118" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments Of Long Term Debt", "negatedLabel": "Payments on long-term debt", "totalLabel": "Repayments of Long-term Debt, Total" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments Of Senior Debt", "terseLabel": "Repayments of Senior Debt", "totalLabel": "Repayments of Senior Debt, Total" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r118" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments Of Short Term Debt", "negatedLabel": "(Payments) borrowings on short-term borrowings, net", "totalLabel": "Repayments of Short-term Debt, Total" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r538", "r733", "r828" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development expense", "totalLabel": "Research and Development Expense, Total" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r538" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research And Development Expense Policy", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r136", "r750", "r779" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails": { "order": 8.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash", "totalLabel": "Restricted Cash, Total" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetScheduleOfComponentOfOtherAssetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashEquivalentsNoncurrent": { "auth_ref": [ "r10", "r19", "r136", "r808", "r809", "r810" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash Equivalents, Noncurrent", "terseLabel": "Restricted cash included in Other assets" } } }, "localname": "RestrictedCashEquivalentsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock Shares Issued Net Of Shares For Tax Withholdings", "terseLabel": "Restricted stock grant, net of shares retained for taxes" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "Unvested restricted shares and restricted stock units", "verboseLabel": "Restricted Stock Units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring And Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r276", "r278", "r281", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring And Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring Costs" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCosts" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": { "auth_ref": [ "r277", "r280", "r286", "r288" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs incurred to date for the specified restructuring cost.", "label": "Restructuring And Related Cost Cost Incurred To Date1", "terseLabel": "Restructuring and related cost, cost incurred to date" } } }, "localname": "RestructuringAndRelatedCostCostIncurredToDate1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedCostIncurredCost": { "auth_ref": [ "r277", "r280", "r286", "r288" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discloses the amount charged against the accrued restructuring reserves, or earnings if not previously accrued, during the period for the specified type of restructuring cost.", "label": "Restructuring And Related Cost Incurred Cost", "terseLabel": "Restructuring and related cost, incurred cost", "totalLabel": "Restructuring and Related Costs, Incurred Cost, Total" } } }, "localname": "RestructuringAndRelatedCostIncurredCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r129", "r275", "r284", "r286" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Restructuring costs", "totalLabel": "Restructuring Charges, Total" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r277", "r278", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Cost And Reserve [Axis]", "terseLabel": "Restructuring Type" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost And Reserve [Line Items]", "terseLabel": "Restructuring Cost And Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCosts": { "auth_ref": [ "r129" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs", "negatedLabel": "Restructuring and severance-related costs", "terseLabel": "Restructuring costs (credits)", "totalLabel": "Total restructuring costs", "verboseLabel": "Restructuring and severance-related costs" } } }, "localname": "RestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserveAcceleratedDepreciation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.", "label": "Restructuring Reserve Accelerated Depreciation", "terseLabel": "Accelerated depreciation" } } }, "localname": "RestructuringReserveAcceleratedDepreciation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r32", "r369", "r530", "r720", "r781", "r802", "r804" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "terseLabel": "Accumulated deficit", "totalLabel": "Retained Earnings (Accumulated Deficit), Total" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r153", "r154", "r155", "r157", "r162", "r164", "r242", "r527", "r528", "r529", "r573", "r574", "r654", "r799", "r801" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanFundingStatusAxis": { "auth_ref": [ "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r461", "r462", "r464", "r465", "r466", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Information by status of funding for defined benefit plan designed to provide retirement benefits.", "label": "Retirement Plan Funding Status [Axis]", "terseLabel": "Defined Benefit Plan, Funding Status" } } }, "localname": "RetirementPlanFundingStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanFundingStatusDomain": { "auth_ref": [ "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r461", "r462", "r464", "r465", "r466", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478" ], "lang": { "en-us": { "role": { "documentation": "Status of funding for defined benefit plan designed to provide retirement benefits.", "label": "Retirement Plan Funding Status [Domain]", "terseLabel": "Defined Benefit Plan, Funding Status" } } }, "localname": "RetirementPlanFundingStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r406", "r407", "r409", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r461", "r462", "r464", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r482", "r483", "r484", "r485", "r486", "r487", "r490", "r491", "r492", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r406", "r407", "r409", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r458", "r459", "r461", "r462", "r464", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r482", "r483", "r484", "r485", "r486", "r487", "r490", "r491", "r492", "r493" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r199", "r200", "r213", "r219", "r220", "r227", "r228", "r232", "r391", "r393", "r734" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails": { "order": 0.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Revenue recognized", "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total", "verboseLabel": "Total Product Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r199", "r200", "r213", "r219", "r220", "r227", "r228", "r232", "r391", "r393", "r734" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue From Contract With Customer Including Assessed Tax", "terseLabel": "Net Revenue", "verboseLabel": "Net revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r189", "r232" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r139", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r404" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r396", "r404" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue From External Customers By Geographic Areas Table [Text Block]", "terseLabel": "Net Revenue by Segment" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueNotFromContractWithCustomer": { "auth_ref": [ "r98" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue that is not accounted for under Topic 606.", "label": "Revenue Not From Contract With Customer", "terseLabel": "Revenue recognized", "verboseLabel": "Collaborations and Other Revenue" } } }, "localname": "RevenueNotFromContractWithCustomer", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r98", "r143", "r199", "r200", "r213", "r219", "r220", "r227", "r228", "r232", "r241", "r301", "r302", "r303", "r306", "r307", "r308", "r310", "r312", "r314", "r315", "r665", "r768" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net revenue", "totalLabel": "Net Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Net revenue" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r699", "r704" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use operating lease assets obtained in exchange for lease obligations" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesSummaryOfCashFlowInformationLeaseTermAndDiscountRateOfOperatingLeaseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleLeasebackTransactionLeaseTerms": { "auth_ref": [ "r689", "r708" ], "lang": { "en-us": { "role": { "documentation": "A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction Lease Terms", "terseLabel": "Initial term" } } }, "localname": "SaleLeasebackTransactionLeaseTerms", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionMonthlyRentalPayments": { "auth_ref": [ "r689" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the monthly rental payments due under the lease entered into in connection with the transactions involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction Monthly Rental Payments", "terseLabel": "Monthly rental payments" } } }, "localname": "SaleLeasebackTransactionMonthlyRentalPayments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale Of Stock Name Of Transaction [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Share price" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule Of Accrued Liabilities Table [Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r85", "r676", "r677" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule Of Accumulated Other Comprehensive Income Loss Table [Text Block]", "terseLabel": "Summary of Accumulated Other Comprehensive Income (Loss), Net of Tax" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.", "label": "Schedule Of Allocation Of Plan Assets Table [Text Block]", "terseLabel": "Schedule of Allocation of Plan Assets" } } }, "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentialOrdinaryShareEquivalentsOutstandingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]", "terseLabel": "Summary of Potential Ordinary Shares Equivalent Excluded from Computation of Net Loss Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Location and Fair Values of Designated and Non-Designated Hedging Instruments Recognized within Consolidated Balance Sheets" } } }, "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.", "label": "Schedule Of Changes In Projected Benefit Obligations Table [Text Block]", "terseLabel": "Schedule of Changes in Projected Benefit Obligations" } } }, "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]", "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]", "terseLabel": "Schedule of Stock-Based Compensation Under Statements Of Operations" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r571" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]", "terseLabel": "Summary of Significant Components of the Income Tax Provision From Continuing Operations" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule Of Debt Table [Text Block]", "terseLabel": "Components of Borrowings" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r463", "r464", "r467", "r468", "r479" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule Of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule Of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsDefinedBenefitPlanPlanAssetsCategoryDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsOtherPostemploymentBenefitsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfChangesInProjectedBenefitObligationAndPlanAssetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureLongTermEmployeeBenefitsSummaryOfNetPeriodicBenefitCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "auth_ref": [ "r463", "r464", "r467", "r468", "r479" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.", "label": "Schedule Of Defined Benefit Plans Disclosures [Text Block]", "terseLabel": "Schedule of Defined Benefit Plans Disclosures" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r633" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.", "label": "Schedule Of Derivative Instruments Effect On Other Comprehensive Income Loss Table [Text Block]", "terseLabel": "Schedule of Designated Derivative Instruments within Interest Expense, Net and Cost of Revenue in Statements of Operations" } } }, "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r628", "r637", "r644" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Schedule Of Derivative Instruments Gain Loss In Statement Of Financial Performance [Text Block]", "terseLabel": "Schedule of Fair value gains and losses of derivative contracts" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r498", "r522", "r532" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.", "label": "Schedule Of Entity Wide Disclosure On Geographic Areas Long Lived Assets In Individual Foreign Countries By Country [Text Block]", "terseLabel": "Property, Plant and Equipment, Net and Right-Of-Use Assets For the Company's Country of Domicile" } } }, "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.", "label": "Schedule Of Expected Benefit Payments Table [Text Block]", "terseLabel": "Schedule of Expected Benefit Payments" } } }, "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r255", "r259", "r735" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule Of Finite Lived Intangible Assets [Table]", "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r255", "r259" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule Of Finite Lived Intangible Assets Table [Text Block]", "terseLabel": "Summary of Gross Carrying Amount and Amortization of Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule Of Goodwill [Table]", "terseLabel": "Schedule Of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r251", "r252" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule Of Goodwill [Text Block]", "terseLabel": "Schedule of Changes In Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]", "terseLabel": "Summary of Income (Loss) from Continuing Operations before Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": { "auth_ref": [ "r637" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.", "label": "Schedule Of Interest Rate Derivatives Table [Text Block]", "terseLabel": "Schedule of Interest Rate Derivatives" } } }, "localname": "ScheduleOfInterestRateDerivativesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r15", "r39", "r40", "r41" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule Of Inventory Current Table [Text Block]", "terseLabel": "Schedule of Inventory, Current" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureInventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule Of Maturities Of Long Term Debt Table [Text Block]", "terseLabel": "Schedule of Required Future Repayments of all Borrowings Outstanding" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r639" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in net investment hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.", "label": "Schedule Of Net Investment Hedges In Accumulated Other Comprehensive Income Loss Table [Text Block]", "terseLabel": "Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfNetInvestmentHedgesInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts related to pension plans and/or other employee benefit plans in accumulated other comprehensive income or loss that have not yet been recognized as components of net periodic benefit cost, such as the net gain (loss), net prior service cost or credit, and net transition asset or obligation.", "label": "Schedule Of Net Periodic Benefit Cost Not Yet Recognized Table [Text Block]", "terseLabel": "Schedule of Net Periodic Benefit Cost Not yet Recognized" } } }, "localname": "ScheduleOfNetPeriodicBenefitCostNotYetRecognizedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLongtermEmployeeBenefitsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions.", "label": "Schedule Of Notional Amounts Of Outstanding Derivative Positions Table [Text Block]", "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions" } } }, "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Schedule Of Other Assets Table [Text Block]", "terseLabel": "Component of Other Assets" } } }, "localname": "ScheduleOfOtherAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r636", "r638" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Schedule Of Other Derivatives Not Designated As Hedging Instruments Statements Of Financial Performance And Financial Position Location Table [Text Block]", "terseLabel": "Derivatives Not Designated as Hedging Instruments" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement.", "label": "Schedule Of Other Operating Cost And Expense By Component [Text Block]", "terseLabel": "Schedule of Other Operating Cost and Expense, by Components" } } }, "localname": "ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureOtherFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r46", "r269" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule Of Property Plant And Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentSEstimatedUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock": { "auth_ref": [ "r269", "r688", "r706" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease [Table Text Block]", "terseLabel": "Equipment Leased to Customers" } } }, "localname": "ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Schedule Of Quarterly Financial Information Table [Text Block]", "terseLabel": "Schedule of Unaudited Quarterly Financial Information" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureUnauditedQuarterlyFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r713", "r714" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule Of Related Party Transactions By Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r277", "r278", "r279", "r280", "r286", "r287", "r288" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule Of Restructuring And Related Costs [Table]", "terseLabel": "Schedule Of Restructuring And Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r282", "r283", "r285" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Schedule Of Restructuring And Related Costs [Text Block]", "terseLabel": "Restructuring and Related Costs" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsTable" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": { "auth_ref": [ "r105", "r228" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]", "terseLabel": "Net revenues for the Company's country of domicile, countries with significant concentrations" } } }, "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r208", "r211", "r217", "r251" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Table]", "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r208", "r211", "r217", "r251" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Text Block]", "terseLabel": "Adjusted EBITDA by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Performance Based Units Vested And Expected To Vest Table [Text Block]", "terseLabel": "Schedule of Performance Based Awards Grant Fair Value" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r499", "r525" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r503", "r512", "r514" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of Option, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r556", "r572" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]", "terseLabel": "Summary of Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r195", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r224", "r232", "r280", "r288", "r793" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment [Domain]", "terseLabel": "Segments" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r195", "r197", "r198", "r208", "r212", "r218", "r222", "r223", "r224", "r225", "r227", "r231", "r232", "r233" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segments and Geographic Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentsAndGeographicInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueByCompanySCountryOfDomicileDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationPPEAndROUAssetsByCompanySCountryOfDomicileDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r108" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling General And Administrative Expense", "terseLabel": "Selling, marketing and administrative expenses", "totalLabel": "Selling, General and Administrative Expense, Total" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, marketing and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r592" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Business Acquisitions [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r129" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance Costs1", "terseLabel": "Severance costs" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r128" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "negatedLabel": "Stock-based compensation", "terseLabel": "Stock based compensation", "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSegmentsAndGeographicInformationManagementEbitdaBySegmentDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Shares, vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number", "periodEndLabel": "Restricted stock units outstanding as of January 2, 2022", "periodStartLabel": "Restricted stock units outstanding as of January 3, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding as of January 2, 2022", "periodStartLabel": "Restricted stock outstanding as of January 3, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period", "negatedLabel": "Vested", "terseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r511" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value", "terseLabel": "Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r519" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Weighted-average dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate", "terseLabel": "Range of expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum", "terseLabel": "Range of expected volatility maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum", "terseLabel": "Range of expected volatility minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Range of risk-free rates" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum", "terseLabel": "Range of risk-free rates maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum", "terseLabel": "Range of risk-free rates minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate", "terseLabel": "Weighted average volatility rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number", "terseLabel": "Exercisable as of January 2, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price", "terseLabel": "Exercisable as of January 2, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period", "negatedLabel": "Canceled", "terseLabel": "Canceled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": { "auth_ref": [ "r513" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Table [Text Block]", "terseLabel": "Assumptions Used to Estimated Grant Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r505", "r525" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Outstanding as of January 2, 2022", "periodStartLabel": "Outstanding as of January 3, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Outstanding as of January 2, 2022", "periodStartLabel": "Outstanding as of January 3, 2021" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Expected to vest as of January 2, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number", "terseLabel": "Total vested and expected to vest as of January 2, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price", "terseLabel": "Total vested and expected to vest as of January 2, 2022" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r497", "r501" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price", "terseLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price", "terseLabel": "Canceled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r499", "r502" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share Based Compensation Option And Incentive Plans Policy", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationScheduleOfPerformanceBasedAwardsGrantFairValueDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage", "terseLabel": "Percentage of vesting award accelerated" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r517", "r531" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Range of expected term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationAssumptionsUsedToEstimatedGrantFairValueDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r525" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1", "terseLabel": "Exercisable as of January 2, 2022" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance", "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance", "terseLabel": "Expected to vest as of January 2, 2022" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value", "terseLabel": "Canceled" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding as of January 2, 2022", "periodStartLabel": "Outstanding as of January 3, 2021", "terseLabel": "Outstanding as of January 3, 2021" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1", "terseLabel": "Total vested and expected to vest as of January 2, 2022" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1", "periodEndLabel": "Outstanding as of January 2, 2022", "periodStartLabel": "Outstanding as of January 3, 2021", "terseLabel": "Weighted average remaining contractual term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value", "terseLabel": "Excercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares Issued", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping And Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r137", "r152" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software And Software Development Costs [Member]", "terseLabel": "Computer software and development costs" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosurePropertyPlantAndEquipmentNetScheduleOfPropertyPlantEquipmentAndAccumulatedDepreciationBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r297", "r298", "r605", "r806" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters Of Credit [Member]", "terseLabel": "Standby Letters of Credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAdministrationOfTaxationChinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government of China.", "label": "State Administration Of Taxation China [Member]", "terseLabel": "Greater China" } } }, "localname": "StateAdministrationOfTaxationChinaMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfChangesInGoodwillDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State And Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r195", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r224", "r232", "r251", "r272", "r280", "r288", "r793" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Statement Business Segments [Axis]", "terseLabel": "Segments" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r26", "r27", "r28", "r141", "r143", "r166", "r167", "r168", "r170", "r172", "r180", "r181", "r182", "r241", "r301", "r306", "r307", "r308", "r314", "r315", "r356", "r357", "r360", "r361", "r363", "r665", "r837" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r63", "r93", "r94", "r95", "r153", "r154", "r155", "r157", "r162", "r164", "r179", "r242", "r363", "r369", "r527", "r528", "r529", "r573", "r574", "r654", "r671", "r672", "r673", "r674", "r675", "r677", "r799", "r800", "r801", "r867" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureFinancialInformationOfRegistrantParentCompanyOnlyAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Income And Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r153", "r154", "r155", "r179", "r734" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherAssetAdditionalInformationDetail", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureOtherFinancialInformationSummaryOfComponentsForCertainCaptionsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitParenthetical", "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r27", "r28", "r363", "r369" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "terseLabel": "Shares, Issued", "verboseLabel": "Issuance of ordinary shares upon completion of initial public offering, net of commissions, underwriting discounts and offering costs, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period Shares Other", "terseLabel": "Issuance of incorporation shares consisting of ordinary shares and preferred redeemable shares, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r27", "r28", "r363", "r369", "r507" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Exercised", "terseLabel": "Exercise of stock options, net of shares retained for taxes, shares", "verboseLabel": "Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureStockbasedCompensationSummaryOfOptionActivityDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r27", "r28", "r363", "r369" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period Shares Stock Splits", "terseLabel": "Stock Issued During Period, Shares, Stock Splits" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureBasisOfPresentationOfTheConsolidatedFinancialStatementsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r27", "r28", "r363", "r369" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of ordinary shares upon completion of initial public offering, net of commissions, underwriting discounts and offering costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Issuance of incorporation shares consisting of ordinary share and preferred redeemable shares" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r63", "r363", "r369" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Exercise of stock options, net of shares retained for taxes" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r27", "r28", "r363", "r369" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period Shares", "negatedLabel": "Share repurchases, shares", "terseLabel": "Share repurchases, Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r27", "r28", "r363", "r369" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period Value", "negatedLabel": "Share repurchases", "terseLabel": "Share repurchases" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r28", "r34", "r35", "r143", "r237", "r241", "r665", "r720" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 }, "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureAccumulatedOtherComprehensiveLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureFinancialInformationOfRegistrantParentCompanyOnlyScheduleOfStatementsOfBalanceSheetsDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets", "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Shareholders' Equity (Deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders Equity Note Stock Split Conversion Ratio1", "terseLabel": "Stock split conversion ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureBasisOfPresentationOfTheConsolidatedFinancialStatementsAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Subsidiary Sale Of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Summary Of Valuation Allowance [Text Block]", "terseLabel": "Summary of Valuation Allowance" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r566" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate": { "auth_ref": [ "r583" ], "lang": { "en-us": { "role": { "documentation": "Percentage of increase (decrease) in effective tax rate for measurement period adjustment from accounting for tax effect pursuant to Tax Cuts and Jobs Act.", "label": "Tax Cuts And Jobs Act Of2017 Measurement Period Adjustment Increase Decrease In Effective Tax Rate", "terseLabel": "Corporate Tax Rate Decrease" } } }, "localname": "TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "us-gaap_TaxPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information about the period subject to enacted tax laws.", "label": "Tax Period [Axis]" } } }, "localname": "TaxPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identified tax period.", "label": "Tax Period [Domain]" } } }, "localname": "TaxPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology Based Intangible Assets [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Corporate Tradename" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureGoodwillAndOtherIntangibleAssetsSummaryOfGrossCarryingAmountAndAccumulatedAmortizationOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r603" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type Of Arrangement [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r277", "r278", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type Of Restructuring [Domain]", "terseLabel": "Type of Restructuring" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureRestructuringCostsAdditionalInfrmationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax": { "auth_ref": [ "r633" ], "calculation": { "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.", "label": "Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax", "negatedLabel": "Unrealized and non-cash foreign exchange losses (gains), net", "totalLabel": "Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax, Total" } } }, "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r539", "r550" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Balance at end of fiscal year", "periodStartLabel": "Balance at beginning of fiscal year", "terseLabel": "Unrecognized tax Benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r551" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions", "negatedLabel": "Decrease related to positions taken on items from prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities", "negatedLabel": "Decrease due to settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r548" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued", "terseLabel": "Unrecognized tax benefit, accrued interest and penalties", "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Expense", "terseLabel": "Unrecognized tax benefit, interest expense and penalties", "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions", "terseLabel": "Increase related to positions taken on items in current years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r551" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions", "terseLabel": "Increase related to positions taken on items from prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "terseLabel": "Increase (Decrease) in Unrecognized Tax Benefits", "totalLabel": "Unrecognized Tax Benefits, Period Increase (Decrease), Total" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations", "terseLabel": "Decrease due to expiration of statutes of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfUnrecognizedTaxBenefitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r555" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits That Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would affect effective income tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r184", "r185", "r186", "r187", "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowingsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number Of Share Outstanding Basic And Diluted", "terseLabel": "Basic and diluted weighted-average ordinary shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "auth_ref": [ "r109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.", "label": "Write Off Of Deferred Debt Issuance Cost", "terseLabel": "Write off of deferred debt Issuance cost" } } }, "localname": "WriteOffOfDeferredDebtIssuanceCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20220102/taxonomy/role/Role_DisclosureBorrowings2028NotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 10 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-04(Schedule I))", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=120391182&loc=d3e5864-122674" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r111": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3095-108585" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3098-108585" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=d3e1280-108306" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL124452896-108306" }, "r178": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r233": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r263": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r274": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r296": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e12803-110250" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r354": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21564-112644" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r4": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r404": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r405": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r408": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r495": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907" }, "r535": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.EE.Q2(g))", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=SL116722634-122817" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r589": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "740", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9972-128506" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "740", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123403335&loc=d3e9979-128506" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r604": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "808", "URI": "http://asc.fasb.org/topic&trid=5833765" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5283-111683" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(6)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "4EEEE", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109999725-113959" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80845-113994" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r656": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r678": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123422147&loc=d3e41457-112716" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123422147&loc=d3e41460-112716" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=123416376&loc=d3e50796-112755" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8,17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r705": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919786-209982" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r716": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(g)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r785": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r829": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580" }, "r830": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r831": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r832": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r833": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r834": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r835": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r836": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r837": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r838": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r839": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "11", "Subsection": "03" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580" }, "r840": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r841": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r842": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r843": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04" }, "r844": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r845": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r846": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r847": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r848": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r849": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580" }, "r850": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r851": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r852": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "a", "Publisher": "SEC", "Section": "12", "Subsection": "04" }, "r853": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01" }, "r854": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "02" }, "r855": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(ii)", "Subsection": "01" }, "r856": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)", "Subsection": "01" }, "r857": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "01" }, "r858": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "02" }, "r859": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "01" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r860": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "02" }, "r861": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(C)", "Subsection": "02" }, "r862": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01" }, "r863": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02" }, "r864": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "i", "Publisher": "SEC", "Section": "3", "Subsection": "10" }, "r865": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r866": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r867": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" } }, "version": "2.1" }